ğ‹‡ Â¦marchÂ¦ Â¦toÂ¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦
ğ‹‡ Â¦cons ul tÂ¦ Â¦theÂ¦ Â¦high li gh tsÂ¦ Â¦fromÂ¦ ğ‹‡ Â¦marchÂ¦ Â¦toÂ¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦
Â¦ser iesÂ¦ Â¦ofÂ¦ Â¦testÂ¦ Â¦t ub esÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦d ra w erÂ¦ 
Â¦3 1Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦jo insÂ¦ Â¦theÂ¦  - Â¦19Â¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦acc essÂ¦ ğ‹‡ Â¦facil ityÂ¦
ğ‹‡Â¦toÂ¦ Â¦acc el er ateÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦andÂ¦ Â¦m an u fa ct ureÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦forÂ¦ Â¦e veryoneÂ¦ Â¦whoÂ¦ Â¦needsÂ¦ Â¦themÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦jo insÂ¦ Â¦theÂ¦ â– â€˜  - Â¦19Â¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦acc essÂ¦ ğ‹‡ Â¦facil ityÂ¦ â€™ .
ğ‹‡ Â¦comm is si on erÂ¦ ğ‹‡ Â¦k y r ia k i desÂ¦ Â¦sign ingÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦contr ac tÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦comp an yÂ¦ ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦
Â¦2 7Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦f orm allyÂ¦ Â¦signsÂ¦ Â¦firstÂ¦ Â¦contr ac tÂ¦ Â¦withÂ¦ ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦contr ac tÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ne g o ti atedÂ¦ Â¦onÂ¦ Â¦be h al fÂ¦ Â¦ofÂ¦ Â¦theÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an yÂ¦ Â¦ent eredÂ¦ Â¦intoÂ¦ Â¦for ceÂ¦ Â¦followingÂ¦ Â¦theÂ¦ Â¦f ormalÂ¦ Â¦sign at ureÂ¦ Â¦betweenÂ¦ ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ .
ğ‹‡ Â¦twoÂ¦ Â¦m enÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦work s ho pÂ¦ 
Â¦2 5Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦provideÂ¦ â– â‚¬ Â¦8 7Â¦ . Â¦3Â¦ Â¦bi ll ionÂ¦ Â¦inÂ¦ Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦forÂ¦ Â¦16Â¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦underÂ¦ 
ğ‹‡Â¦onÂ¦ Â¦24Â¦ Â¦andÂ¦ Â¦2 5Â¦ ğ‹‡ Â¦a u g ustÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entedÂ¦ Â¦prop os alsÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦toÂ¦ Â¦gr antÂ¦ Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦ofÂ¦ â– â‚¬ Â¦8 7Â¦ .
Â¦res ear c herÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦laboratoryÂ¦ 
Â¦20Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦contin uesÂ¦ Â¦exp an dingÂ¦ Â¦f ut ureÂ¦ Â¦vaccinesÂ¦ Â¦p ort f o li oÂ¦ Â¦throughÂ¦ Â¦newÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡Â¦c u re ğ‹‡ v a cÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦co nc lu dedÂ¦ Â¦ex pl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡Â¦c u re ğ‹‡ v a cÂ¦ Â¦toÂ¦ Â¦pote nt iallyÂ¦ Â¦p ur ch aseÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
ğ‹‡Â¦aÂ¦ Â¦sc ie nt istÂ¦ Â¦atÂ¦ Â¦workÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦l ab Â¦ 
Â¦14Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦rea chesÂ¦ Â¦firstÂ¦ Â¦ag r ee mentÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦pote ntialÂ¦ Â¦vaccineÂ¦ Â¦withÂ¦ ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦rea chedÂ¦ Â¦aÂ¦ Â¦firstÂ¦ Â¦ag r ee mentÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an yÂ¦ ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦ Â¦toÂ¦ Â¦p ur ch aseÂ¦ Â¦aÂ¦ Â¦pote ntialÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
ğ‹‡ Â¦res ear c herÂ¦ Â¦wor kingÂ¦ Â¦onÂ¦ Â¦vaccineÂ¦ 
Â¦13Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦co nc lu desÂ¦ Â¦furtherÂ¦ Â¦t al ksÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦f ut ureÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦co nc lu dedÂ¦ Â¦ex pl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡ Â¦jo h ns onÂ¦ â– & â– ğ‹‡ Â¦jo h ns onÂ¦ Â¦toÂ¦ Â¦p ur ch aseÂ¦ Â¦aÂ¦ Â¦pote ntialÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ :â– â€œ ğ‹‡ Â¦ourÂ¦ Â¦c itiz ensÂ¦ ' â– Â¦l ivesÂ¦ Â¦andÂ¦ Â¦ourÂ¦ Â¦ec on om yÂ¦ Â¦needÂ¦ Â¦aÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦researchÂ¦ Â¦l ab Â¦ 
Â¦11Â¦ ğ‹‡ Â¦a u g ustÂ¦ Â¦2020Â¦ â–-â– Â¦23Â¦ Â¦newÂ¦ Â¦researchÂ¦ Â¦pro j ectsÂ¦ Â¦toÂ¦ Â¦receiveÂ¦ â– â‚¬ Â¦1 2 8Â¦ Â¦millionÂ¦ Â¦inÂ¦  Â¦f un dingÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦willÂ¦ Â¦supportÂ¦ Â¦23Â¦ Â¦newÂ¦ Â¦researchÂ¦ Â¦pro j ectsÂ¦ Â¦withÂ¦ â– â‚¬ Â¦1 2 8Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦c ri sisÂ¦ .
ğ‹‡ Â¦sa no f iÂ¦ Â¦t al ksÂ¦ 
Â¦3 1Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦co nc lu desÂ¦ Â¦t al ksÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦aÂ¦ Â¦f ut ureÂ¦ Â¦coronavirusÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦co nc lu dedÂ¦ Â¦ex pl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an yÂ¦ ğ‹‡ Â¦sa no f iÂ¦ Â¦toÂ¦ Â¦p ur ch aseÂ¦ Â¦aÂ¦ Â¦pote ntialÂ¦  - Â¦19Â¦ Â¦vaccineÂ¦ .
Â¦sc ie nt istÂ¦ 
Â¦2 9Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦sec uresÂ¦  Â¦acc essÂ¦ Â¦toÂ¦ ğ‹‡ Â¦rem de si vi rÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦sign edÂ¦ Â¦aÂ¦ â– â‚¬ Â¦6 3Â¦ Â¦millionÂ¦ Â¦contr ac tÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an yÂ¦ ğ‹‡ Â¦g il eadÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦treatmentÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ ve k lu ryÂ¦ ,â– Â¦theÂ¦ Â¦br andÂ¦ Â¦na meÂ¦ Â¦forÂ¦ ğ‹‡ Â¦rem de si vi rÂ¦ .
Â¦hand s h a keÂ¦ 
Â¦2 7Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦la un chesÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦in n ov ativeÂ¦ Â¦responseÂ¦ Â¦andÂ¦ Â¦reco ve ryÂ¦ Â¦part ne rs hi psÂ¦ Â¦betweenÂ¦  Â¦regi onsÂ¦
ğ‹‡Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦responseÂ¦ Â¦andÂ¦ Â¦reco ve ryÂ¦ ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦regi onsÂ¦ Â¦se iz eÂ¦ Â¦o pp ort un itiesÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦la u nc hingÂ¦ Â¦aÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦exp r es si onsÂ¦ Â¦ofÂ¦ Â¦inter estÂ¦ Â¦forÂ¦ Â¦in n ov ationÂ¦ Â¦pro j ectsÂ¦ Â¦betweenÂ¦ Â¦regi onsÂ¦ ,â– Â¦f oc us ingÂ¦ Â¦onÂ¦ Â¦fourÂ¦ Â¦the m at icÂ¦ Â¦areasÂ¦ :â– Â¦developmentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦medicalÂ¦ Â¦v al ueÂ¦ Â¦cha inÂ¦ ;â– Â¦safetyÂ¦ Â¦andÂ¦ Â¦mana ge mentÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦w a st eÂ¦ ;â– Â¦s us ta in ableÂ¦ Â¦andÂ¦ Â¦d ig it alÂ¦ Â¦to ur is mÂ¦ ;â– Â¦andÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦h y dr og enÂ¦ Â¦techn ol og iesÂ¦ Â¦inÂ¦ Â¦car b onÂ¦ - Â¦in tens iveÂ¦ Â¦regi onsÂ¦ .
ğ‹‡ Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ 
Â¦23Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ :â– â€œ ğ‹‡Â¦t og etherÂ¦ ,â– Â¦weÂ¦ Â¦n owÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦ch anceÂ¦ Â¦toÂ¦ Â¦a ch ie veÂ¦ Â¦so me thingÂ¦ Â¦h ist or icÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ . â€
ğ‹‡ Â¦followingÂ¦ Â¦anÂ¦ Â¦ag r ee mentÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦onÂ¦ ğ‹‡Â¦e ur opeÂ¦ â€™ Â¦sÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ ğ‹‡ Â¦pl anÂ¦ ,â– ğ‹‡Â¦c om mi ssionÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ :â– â€œ ğ‹‡Â¦weÂ¦ Â¦n owÂ¦ Â¦haveÂ¦ Â¦ma ss iveÂ¦ Â¦andÂ¦ Â¦un p r ec ed entedÂ¦ Â¦fi na nc ialÂ¦ Â¦fi re p owerÂ¦ â–-â– â‚¬ Â¦1Â¦ .
Â¦b ud g etÂ¦ 
Â¦ 21Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ Â¦lea d ersÂ¦ Â¦rea chÂ¦ Â¦aÂ¦ Â¦de alÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦reco ve ryÂ¦ Â¦pl anÂ¦ Â¦andÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦longÂ¦ - Â¦ter mÂ¦ Â¦b ud g etÂ¦ Â¦2021Â¦ - Â¦20 2 7Â¦
ğ‹‡ Â¦afterÂ¦ Â¦4Â¦ Â¦longÂ¦ Â¦daysÂ¦ Â¦andÂ¦ Â¦n i gh tsÂ¦ Â¦ofÂ¦ Â¦ne g o ti ationsÂ¦ ,â–  Â¦lea d ersÂ¦ Â¦s uc cess f ul lyÂ¦ Â¦ag re edÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦reco ve ryÂ¦ Â¦pl anÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ .
Â¦testingÂ¦ Â¦l ab Â¦ Â¦ im ageÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦st re ng th ensÂ¦ Â¦pre par ed nessÂ¦ Â¦forÂ¦ Â¦possibleÂ¦ Â¦f ut ureÂ¦ Â¦coronavirusÂ¦ Â¦out b rea ksÂ¦
ğ‹‡ Â¦whileÂ¦ Â¦a im ingÂ¦ Â¦toÂ¦ Â¦sa veÂ¦ Â¦l ivesÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦loc k d ow nsÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦s ettingÂ¦ Â¦outÂ¦ Â¦immediateÂ¦ Â¦sh ortÂ¦ - Â¦ter mÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦st re ng th enÂ¦  Â¦healthÂ¦ Â¦pre par ed nessÂ¦ Â¦inÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦possibleÂ¦ Â¦f ut ureÂ¦ Â¦coronavirusÂ¦ Â¦out b rea ksÂ¦ .
ğ‹‡ Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ ,â– ğ‹‡ Â¦pres identÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦sp ee kingÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦pres identÂ¦ ğ‹‡ Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ :â– Â¦weÂ¦ Â¦canÂ¦ Â¦e mer geÂ¦ Â¦st ro ngerÂ¦ Â¦fromÂ¦ Â¦thisÂ¦ Â¦c ri sisÂ¦
ğ‹‡Â¦whenÂ¦ Â¦add re ss ingÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦occ as ionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦star tÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦g erm anÂ¦ ğ‹‡ Â¦pres ide ncyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦ofÂ¦ Â¦theÂ¦  ,â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ :â– â€œ ğ‹‡Â¦s ol id ar ityÂ¦ Â¦me ansÂ¦ Â¦thatÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦needÂ¦ Â¦itÂ¦ ,â– Â¦getÂ¦ Â¦moreÂ¦ Â¦supportÂ¦ .
Â¦mo ne yÂ¦ Â¦e u ro sÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦su mm erÂ¦ Â¦2020Â¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦ :â– ğ‹‡ Â¦u ne v enÂ¦ Â¦reco ve ryÂ¦ Â¦exp ectedÂ¦ Â¦toÂ¦ Â¦ga inÂ¦ Â¦tra ctionÂ¦ Â¦inÂ¦ Â¦secondÂ¦ Â¦h al fÂ¦ Â¦ofÂ¦ Â¦2020Â¦
ğ‹‡Â¦d esp iteÂ¦ Â¦theÂ¦ Â¦sw if tÂ¦ Â¦andÂ¦ Â¦comp re he ns iveÂ¦ Â¦pol ic yÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦corona Â¦ - Â¦c ri sisÂ¦ Â¦atÂ¦ Â¦bothÂ¦  Â¦andÂ¦ Â¦nationalÂ¦ Â¦le v elsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦su mm erÂ¦ Â¦2020Â¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦ Â¦pro j ectsÂ¦ Â¦aÂ¦ Â¦d ee pÂ¦ Â¦rece ssionÂ¦ Â¦inÂ¦ Â¦theÂ¦  Â¦ec on om yÂ¦ Â¦thisÂ¦ Â¦yearÂ¦ .
Â¦1Â¦ ğ‹‡ Â¦j u lyÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦y ou thÂ¦ ğ‹‡Â¦e mploy mentÂ¦ ğ‹‡ Â¦supportÂ¦ :â– Â¦aÂ¦ Â¦br id geÂ¦ Â¦toÂ¦ Â¦j ob sÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦ne xtÂ¦ Â¦gener ationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur op e ansÂ¦
ğ‹‡Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦hasÂ¦ Â¦e m ph a si sedÂ¦ Â¦theÂ¦ Â¦oftenÂ¦ Â¦diffic ul tÂ¦ Â¦star tÂ¦ Â¦manyÂ¦ Â¦y ou ngÂ¦ Â¦peopleÂ¦ Â¦faceÂ¦ ,â– Â¦butÂ¦ Â¦y ou ngÂ¦ ğ‹‡Â¦e ur op e ansÂ¦ Â¦d es er veÂ¦ Â¦theÂ¦ Â¦b estÂ¦ Â¦o pp ort un itiesÂ¦ Â¦thatÂ¦ ğ‹‡Â¦e ur opeÂ¦ Â¦canÂ¦ Â¦off erÂ¦ .
ğ‹‡ Â¦globalÂ¦ Â¦responseÂ¦ Â¦ev entÂ¦ 
Â¦2 7Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ Â¦pl ed gingÂ¦ Â¦s um mi tÂ¦ Â¦m ob i li sesÂ¦ Â¦anotherÂ¦ â– â‚¬ Â¦6Â¦ .
ğ‹‡Â¦theÂ¦ â– â€˜ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦go alÂ¦ :â– ğ‹‡ Â¦un iteÂ¦ Â¦forÂ¦ Â¦ourÂ¦ ğ‹‡Â¦f ut ureÂ¦ ' â– Â¦pl ed gingÂ¦ Â¦s um mi tÂ¦ Â¦or g an i sedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦andÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c itiz enÂ¦ Â¦onÂ¦ Â¦2 7Â¦ ğ‹‡ Â¦juneÂ¦ Â¦m ob i li sedÂ¦ â– â‚¬ Â¦6Â¦ .
ğ‹‡ Â¦globalÂ¦ Â¦responseÂ¦ Â¦ev entÂ¦ 
Â¦26Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– Â¦t un eÂ¦ Â¦inÂ¦ Â¦toÂ¦ Â¦s um mi tÂ¦ Â¦andÂ¦ Â¦concer tÂ¦ Â¦onÂ¦ ğ‹‡Â¦s at ur dayÂ¦ ,â– Â¦2 7Â¦ ğ‹‡ Â¦juneÂ¦ Â¦atÂ¦ Â¦3 p mÂ¦  .
ğ‹‡Â¦theÂ¦ Â¦globalÂ¦ Â¦pl ed gingÂ¦ Â¦s um mi tÂ¦ Â¦andÂ¦ Â¦concer tÂ¦ Â¦or g an i sedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦andÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c itiz enÂ¦ Â¦isÂ¦ Â¦happ eningÂ¦ Â¦thisÂ¦ ğ‹‡Â¦s at ur dayÂ¦ â–( Â¦2 7Â¦ ğ‹‡ Â¦juneÂ¦ ).
ğ‹‡ Â¦coronavirusÂ¦ Â¦globalÂ¦ Â¦responseÂ¦ 
Â¦2 2Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦an no un cesÂ¦ Â¦worldÂ¦ Â¦lea d ersÂ¦ â€™ â– Â¦s um mi tÂ¦ Â¦andÂ¦ Â¦concer tÂ¦ Â¦ lineÂ¦ - Â¦upÂ¦ Â¦forÂ¦ Â¦2 7Â¦ ğ‹‡ Â¦juneÂ¦ Â¦pl ed gingÂ¦ Â¦ev entÂ¦
ğ‹‡ Â¦ar ti stsÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦p owerÂ¦ Â¦toÂ¦ Â¦i ns p ir eÂ¦ Â¦ch angeÂ¦ .
Â¦1 7Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â–   - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦stra te g yÂ¦ Â¦un ve il edÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦pres entedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦stra te g yÂ¦ Â¦toÂ¦ Â¦acc el er ateÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ ,â– Â¦m an u fa ct ur ingÂ¦ Â¦andÂ¦ Â¦dep lo y mentÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦vaccinesÂ¦ Â¦asÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦ourÂ¦ Â¦b estÂ¦ Â¦b etÂ¦ Â¦atÂ¦ Â¦per ma ne ntlyÂ¦ Â¦be atingÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦withinÂ¦ Â¦aÂ¦ Â¦ti me f ra meÂ¦ Â¦ofÂ¦ Â¦12Â¦ Â¦toÂ¦ Â¦18Â¦ Â¦mon thsÂ¦ ,â– Â¦ifÂ¦ Â¦notÂ¦ Â¦ ear li erÂ¦ .
Â¦reop enÂ¦ Â¦euÂ¦ Â¦v is ualÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– â€˜ ğ‹‡ Â¦r eÂ¦ - Â¦openÂ¦  â€™ â–â€“â– Â¦aÂ¦ Â¦newÂ¦ Â¦we b Â¦ Â¦pl at for mÂ¦ Â¦la un chedÂ¦ Â¦toÂ¦ Â¦sa f elyÂ¦ Â¦res u meÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦andÂ¦ Â¦to ur is mÂ¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦la un chedÂ¦ â– â€˜ ğ‹‡ Â¦r eÂ¦ - Â¦openÂ¦  â€™ ,â– Â¦aÂ¦ Â¦we b Â¦ Â¦pl at for mÂ¦ Â¦thatÂ¦ Â¦conta insÂ¦ Â¦essentialÂ¦ Â¦informationÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦safeÂ¦ Â¦re la un chÂ¦ Â¦ofÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦andÂ¦ Â¦to ur is mÂ¦ Â¦acrossÂ¦ ğ‹‡Â¦e ur opeÂ¦ ,â– Â¦soÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦conf ide ntlyÂ¦ Â¦canÂ¦ Â¦en j o yÂ¦ Â¦yourÂ¦ Â¦up c om ingÂ¦ Â¦h ol id aysÂ¦ .
Â¦m anÂ¦ Â¦withÂ¦ Â¦maskÂ¦ Â¦chec kingÂ¦ Â¦hi sÂ¦ Â¦phoneÂ¦ 
Â¦10Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â–  Â¦ste psÂ¦ Â¦upÂ¦ Â¦a ctionÂ¦ Â¦toÂ¦ Â¦f ightÂ¦ Â¦coronavirusÂ¦ Â¦disinf orm ationÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦highÂ¦ ğ‹‡ Â¦rep re se nt ativeÂ¦ Â¦areÂ¦ Â¦ste ppingÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦f ightÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ Â¦disinf orm ationÂ¦ Â¦byÂ¦ Â¦prop os ingÂ¦ Â¦aÂ¦ Â¦wayÂ¦ Â¦for w ardÂ¦ Â¦inÂ¦ Â¦aÂ¦ ğ‹‡ Â¦jo in tÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ .
ğ‹‡ Â¦int eri orÂ¦ Â¦ofÂ¦ Â¦anÂ¦ Â¦in n ov ationÂ¦ Â¦l ab Â¦ 
Â¦8Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦toÂ¦ Â¦f ightÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦reco ve ryÂ¦ ,â–  Â¦g ra ntsÂ¦ â– â‚¬ Â¦3 1 4Â¦ Â¦millionÂ¦ Â¦toÂ¦ Â¦in n ov ativeÂ¦ Â¦comp an iesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦a w ar dedÂ¦ Â¦3 6Â¦ Â¦comp an iesÂ¦ Â¦withÂ¦ Â¦ne arlyÂ¦ â– â‚¬ Â¦1 6 6Â¦ Â¦millionÂ¦ ,â– Â¦v iaÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦in n ov ationÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ ğ‹‡ Â¦acc el erat orÂ¦ ğ‹‡Â¦p il otÂ¦ ,â– Â¦willÂ¦ Â¦workÂ¦ Â¦onÂ¦ Â¦p i o ne eringÂ¦ Â¦pro j ectsÂ¦ :â– Â¦bi oÂ¦ - Â¦dec on ta m inationÂ¦ Â¦w ip esÂ¦ ,â– Â¦develop ingÂ¦ Â¦lowÂ¦ - Â¦c ostÂ¦ Â¦m assÂ¦ Â¦c as u al t yÂ¦ Â¦ ventil ationÂ¦ Â¦monit or ingÂ¦ Â¦sys temsÂ¦ ,â– Â¦andÂ¦ Â¦anÂ¦ Â¦antibo dyÂ¦ Â¦pl at for mÂ¦ Â¦toÂ¦ Â¦tre atÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pl ed gesÂ¦ â– â‚¬ Â¦3 00Â¦ Â¦millionÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦al li anceÂ¦
ğ‹‡Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦juneÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ â– â‚¬ Â¦3 00Â¦ Â¦millionÂ¦ Â¦pl ed geÂ¦ Â¦toÂ¦ ğ‹‡ Â¦ga v iÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡ Â¦al li anceÂ¦ ,â– Â¦forÂ¦ Â¦theÂ¦ Â¦periodÂ¦ Â¦2021Â¦ â€“ Â¦20 2 5Â¦ 
Â¦3Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦ta k esÂ¦ Â¦firstÂ¦ Â¦ste pÂ¦ Â¦t ow ardsÂ¦ Â¦ad o ptionÂ¦ Â¦ofÂ¦ Â¦aÂ¦ ğ‹‡ Â¦ph ar ma ce ut icalÂ¦ ğ‹‡ Â¦stra te g yÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦publ ishedÂ¦ Â¦aÂ¦ Â¦ro a d ma pÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦ph ar ma ce ut icalÂ¦ ğ‹‡ Â¦stra te g yÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ .
Â¦globalÂ¦ Â¦responseÂ¦ 
Â¦2 8Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– â€œ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦go alÂ¦ :â– ğ‹‡ Â¦un iteÂ¦ ğ‹‡Â¦forÂ¦ ğ‹‡ Â¦ourÂ¦ ğ‹‡Â¦f ut ureÂ¦ â€ â– Â¦k ickÂ¦ - Â¦off Â¦ Â¦withÂ¦ Â¦supportÂ¦ Â¦fromÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c itiz enÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ Â¦wasÂ¦ Â¦k ickÂ¦ - Â¦star tedÂ¦ Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ Â¦andÂ¦ Â¦hasÂ¦ Â¦soÂ¦ Â¦fa rÂ¦ Â¦r ai sedÂ¦ â– â‚¬ Â¦9Â¦ , Â¦8Â¦ Â¦bi ll ionÂ¦ Â¦forÂ¦ Â¦univers alÂ¦ Â¦acc essÂ¦ Â¦toÂ¦ Â¦aff or d ableÂ¦ Â¦coronavirusÂ¦ Â¦vacc inationÂ¦ ,â– Â¦tre at mentsÂ¦ Â¦andÂ¦ Â¦testingÂ¦ .
ğ‹‡ Â¦reco ve ryÂ¦ Â¦pl anÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ 
Â¦2 7Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦e ur opeÂ¦ â€™ Â¦sÂ¦ Â¦mo mentÂ¦ :â– Â¦majorÂ¦ â– â‚¬ Â¦2Â¦ , Â¦4Â¦ Â¦t ri ll ionÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ ğ‹‡ Â¦pl anÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ Â¦un ve il edÂ¦ Â¦toÂ¦ Â¦rep ai rÂ¦ Â¦andÂ¦ Â¦pre p areÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦ne xtÂ¦ Â¦gener ationÂ¦
ğ‹‡Â¦toÂ¦ Â¦k ickÂ¦ - Â¦star tÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦reco ve ryÂ¦ ,â– Â¦protectÂ¦ Â¦l ivesÂ¦ ,â– Â¦li ve li h oo dsÂ¦ Â¦andÂ¦ Â¦j ob sÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦prop os ingÂ¦ Â¦aÂ¦ Â¦majorÂ¦ â– â‚¬ Â¦2Â¦ , Â¦4Â¦ Â¦t ri ll ionÂ¦ Â¦reco ve ryÂ¦ Â¦pl anÂ¦ Â¦whichÂ¦ Â¦isÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦usingÂ¦ Â¦theÂ¦ Â¦f ul lÂ¦ Â¦pote ntialÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦p ow er fulÂ¦ ,â– Â¦mod er nÂ¦ Â¦andÂ¦ Â¦re v a mp edÂ¦  Â¦b ud g etÂ¦ Â¦toÂ¦ Â¦de li verÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦s us ta in ableÂ¦ ,â– Â¦d ig it alÂ¦ ,â– Â¦inclu s iveÂ¦ Â¦andÂ¦ Â¦f ai rÂ¦ ğ‹‡Â¦e ur opeÂ¦ 
Â¦26Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ Â¦s ol id ar ityÂ¦ :â–  ğ‹‡ Â¦ind u st ryÂ¦ Â¦ste psÂ¦ Â¦inÂ¦ Â¦toÂ¦ Â¦protectÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦c itiz ensÂ¦
ğ‹‡ Â¦europeanÂ¦ Â¦comp an iesÂ¦ Â¦haveÂ¦ Â¦sh ownÂ¦ Â¦ext ra or d in aryÂ¦ Â¦s ol id ar ityÂ¦ Â¦inÂ¦ Â¦thisÂ¦ Â¦c ri sisÂ¦ .
 Â¦se m es terÂ¦ 
Â¦20Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦se m es terÂ¦ ğ‹‡ Â¦sp r ingÂ¦ ğ‹‡Â¦p ac k ageÂ¦ :â– ğ‹‡ Â¦recomm end ationsÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦co or d in atedÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦onÂ¦ Â¦20Â¦ ğ‹‡ Â¦mayÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop osedÂ¦ Â¦countryÂ¦ - Â¦specificÂ¦ Â¦recomm end ationsÂ¦ Â¦forÂ¦ Â¦allÂ¦  ğ‹‡ Â¦me mbersÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ ,â– Â¦basedÂ¦ Â¦up onÂ¦ Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ â€™ Â¦sÂ¦ Â¦gr ow thÂ¦ Â¦stra te g yÂ¦ ,â– Â¦whichÂ¦ Â¦pro mo tesÂ¦ Â¦comp e ti tiveÂ¦ Â¦su st ai na bilityÂ¦ Â¦toÂ¦ Â¦bu i ldÂ¦ Â¦anÂ¦ Â¦ec on om yÂ¦ Â¦thatÂ¦ Â¦wor ksÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦pl an etÂ¦ .
Â¦res ear c herÂ¦ Â¦covidÂ¦ - Â¦19Â¦ 
Â¦19Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦coronavirusÂ¦ Â¦researchÂ¦ Â¦ bo os tedÂ¦ Â¦byÂ¦ â– â‚¬ Â¦1 2 2Â¦ Â¦millionÂ¦ Â¦ofÂ¦ Â¦ad di tionalÂ¦ Â¦f un dingÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦m ob i li sedÂ¦ Â¦anotherÂ¦ â– â‚¬ Â¦1 2 2Â¦ Â¦millionÂ¦ Â¦fromÂ¦ Â¦itsÂ¦ Â¦researchÂ¦ Â¦andÂ¦ Â¦in n ov ationÂ¦ Â¦pr ogra m meÂ¦ ,â– ğ‹‡Â¦h or iz onÂ¦ Â¦2020Â¦ ,â– Â¦forÂ¦ Â¦ ur ge ntlyÂ¦ Â¦nee dedÂ¦ Â¦researchÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
Â¦air p ortÂ¦ 
Â¦13Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦sa f elyÂ¦ Â¦res um ingÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦re b oo tingÂ¦ ğ‹‡Â¦e ur opeÂ¦ â€™ Â¦sÂ¦ Â¦to ur is mÂ¦ :â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦ta k esÂ¦ Â¦a ctionÂ¦
ğ‹‡Â¦toÂ¦ Â¦all owÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦takeÂ¦ Â¦h ol id aysÂ¦ Â¦andÂ¦ Â¦c at chÂ¦ Â¦upÂ¦ Â¦withÂ¦ Â¦theirÂ¦ Â¦f ri endsÂ¦ Â¦andÂ¦ Â¦fa m il iesÂ¦ ,â– Â¦toÂ¦ Â¦l etÂ¦ Â¦to ur is mÂ¦ Â¦b us in es sesÂ¦ Â¦reop enÂ¦ Â¦afterÂ¦ Â¦mon thsÂ¦ Â¦ofÂ¦ Â¦beingÂ¦ Â¦loc kedÂ¦ Â¦downÂ¦ ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦helpÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦helpÂ¦ Â¦g rad uallyÂ¦ Â¦l if tÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦whileÂ¦ Â¦resp ectingÂ¦ Â¦theÂ¦ Â¦ne cess aryÂ¦ Â¦healthÂ¦ Â¦pr ec a u tionsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entedÂ¦ Â¦aÂ¦ Â¦s etÂ¦ Â¦ofÂ¦ Â¦gu id el inesÂ¦ Â¦andÂ¦ Â¦recomm end ationsÂ¦ Â¦forÂ¦ Â¦tou ri stsÂ¦ ,â– Â¦tra ve ll ersÂ¦ Â¦andÂ¦ Â¦b us in es sesÂ¦ .
ğ‹‡ Â¦medicalÂ¦ Â¦researchÂ¦ 
Â¦12Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ - â– â‚¬ Â¦1 1 7Â¦ Â¦millionÂ¦ Â¦gr an tedÂ¦ Â¦forÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦tre at mentsÂ¦ Â¦andÂ¦ Â¦diagn o st icsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦s el ectedÂ¦ Â¦8Â¦ Â¦largeÂ¦ - Â¦sc a leÂ¦ Â¦researchÂ¦ Â¦pro j ectsÂ¦ Â¦ ai medÂ¦ Â¦atÂ¦ Â¦develop ingÂ¦ Â¦tre at mentsÂ¦ Â¦andÂ¦ Â¦diagn o st icsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦inÂ¦ Â¦aÂ¦ Â¦f astÂ¦ - Â¦tr ackÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦prop os alsÂ¦ Â¦la un chedÂ¦ Â¦inÂ¦ ğ‹‡ Â¦marchÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦in n ov ativeÂ¦ ğ‹‡ Â¦medic inesÂ¦ ğ‹‡ Â¦in i ti ativeÂ¦ â–(  ),â– Â¦aÂ¦ Â¦publicÂ¦ - Â¦priv ateÂ¦ Â¦part ne rs hi pÂ¦ .
Â¦masksÂ¦ Â¦de li ve ryÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ Â¦s ol id ar ityÂ¦ Â¦inÂ¦ Â¦a ctionÂ¦ â–â€“â–  Â¦masksÂ¦ Â¦del iv eredÂ¦ Â¦toÂ¦ ğ‹‡Â¦n or thÂ¦ ğ‹‡Â¦m ac ed on iaÂ¦ Â¦andÂ¦ ğ‹‡ Â¦mon te ne g r oÂ¦
ğ‹‡ Â¦followingÂ¦ Â¦prev iousÂ¦ Â¦de li ver iesÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦ ,â– ğ‹‡Â¦s pa inÂ¦ Â¦andÂ¦ ğ‹‡Â¦c ro at iaÂ¦ ,â– Â¦ad di tionalÂ¦ Â¦b at chesÂ¦ Â¦ofÂ¦ Â¦masksÂ¦ Â¦areÂ¦ Â¦beingÂ¦ Â¦del iv eredÂ¦ Â¦toÂ¦ ğ‹‡Â¦n or thÂ¦ ğ‹‡Â¦m ac ed on iaÂ¦ Â¦andÂ¦ ğ‹‡ Â¦mon te ne g r oÂ¦ Â¦v iaÂ¦  â–â€“â– Â¦theÂ¦ Â¦commonÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦res er veÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦countriesÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦masksÂ¦ Â¦de li ve ryÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ Â¦s ol id ar ityÂ¦ Â¦inÂ¦ Â¦a ctionÂ¦ â–â€“â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦del iv ersÂ¦ Â¦firstÂ¦ Â¦b at chÂ¦ Â¦ofÂ¦ Â¦1Â¦ . Â¦5Â¦ Â¦millionÂ¦ Â¦masksÂ¦ Â¦toÂ¦ Â¦supportÂ¦  Â¦healthÂ¦ Â¦workersÂ¦
ğ‹‡Â¦aÂ¦ Â¦firstÂ¦ Â¦b at chÂ¦ Â¦ofÂ¦ Â¦1Â¦ , Â¦5Â¦ Â¦millionÂ¦ Â¦medicalÂ¦ Â¦masksÂ¦ Â¦isÂ¦ Â¦beingÂ¦ Â¦del iv eredÂ¦ Â¦toÂ¦ Â¦1 7Â¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦andÂ¦ Â¦theÂ¦  Â¦toÂ¦ Â¦protectÂ¦ Â¦healthcareÂ¦ Â¦workersÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ .
Â¦high l ightÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦h el psÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦ad dr essÂ¦ Â¦theÂ¦ Â¦sh or ta gesÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ Â¦workersÂ¦ Â¦sp e edÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦reco gn itionÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ Â¦workersÂ¦ â€™ â– Â¦pro f es si on alÂ¦ Â¦qu al if icationsÂ¦
ğ‹‡Â¦toÂ¦ Â¦helpÂ¦ Â¦ad dr essÂ¦ Â¦theÂ¦ Â¦sh or ta gesÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ Â¦workersÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦issuedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ Â¦whichÂ¦ Â¦provid esÂ¦ Â¦gu id anceÂ¦ Â¦forÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ .
ğ‹‡ Â¦ma pÂ¦ Â¦ofÂ¦ Â¦sp r ingÂ¦ Â¦ec onomicÂ¦ Â¦for ec astÂ¦ 
Â¦6Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦sp r ingÂ¦ Â¦2020Â¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦ â–â€“â– Â¦rece ssionÂ¦ Â¦andÂ¦ Â¦reco ve ryÂ¦
ğ‹‡Â¦d esp iteÂ¦ Â¦theÂ¦ Â¦sw if tÂ¦ Â¦andÂ¦ Â¦dec is iveÂ¦  Â¦andÂ¦ Â¦nationalÂ¦ Â¦resp on sesÂ¦ ,â– Â¦theÂ¦  Â¦ec on om yÂ¦ Â¦willÂ¦ Â¦exp eri enceÂ¦ Â¦aÂ¦ Â¦rece ssionÂ¦ Â¦thisÂ¦ Â¦yearÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦ca meÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦majorÂ¦ Â¦ec onomicÂ¦ Â¦sh oc kÂ¦ .
ğ‹‡Â¦p i ct ureÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ :â– â‚¬ Â¦7Â¦ , Â¦4Â¦ Â¦bi ll ionÂ¦ Â¦r ai sedÂ¦ Â¦fromÂ¦ Â¦d on orsÂ¦ Â¦worldwideÂ¦ Â¦forÂ¦ Â¦univers alÂ¦ Â¦acc essÂ¦ Â¦toÂ¦ Â¦vaccinesÂ¦ â–
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦reg ist eredÂ¦ â– â‚¬ Â¦7Â¦ .
ğ‹‡Â¦p i ct ureÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦b an n erÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y m on tÂ¦ Â¦bu il dingÂ¦ 
Â¦2Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦f in alÂ¦ Â¦cou nt d ownÂ¦ :â– ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ Â¦pl ed gingÂ¦ Â¦m ara th onÂ¦ Â¦star tsÂ¦ Â¦onÂ¦ ğ‹‡ Â¦mon dayÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦
ğ‹‡ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦un ionÂ¦ Â¦isÂ¦ Â¦j oi ningÂ¦ Â¦for cesÂ¦ Â¦withÂ¦ Â¦globalÂ¦ Â¦part n ersÂ¦ Â¦toÂ¦ Â¦k ickÂ¦ - Â¦star tÂ¦ Â¦aÂ¦ Â¦worldwideÂ¦ Â¦pl ed gingÂ¦ Â¦eff ortÂ¦ Â¦toÂ¦ Â¦develop Â¦ Â¦tre at mentsÂ¦ ,â– Â¦vaccinesÂ¦ Â¦andÂ¦ Â¦diagn o st icsÂ¦ .
ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ :â– â€œ ğ‹‡Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ ,â– Â¦weÂ¦ Â¦w antÂ¦ Â¦toÂ¦ Â¦br ingÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦t og etherÂ¦ Â¦toÂ¦ Â¦de li verÂ¦ Â¦onÂ¦ Â¦pre ventionÂ¦ ,â– Â¦diagn o st icsÂ¦ Â¦andÂ¦ Â¦tre at mentsÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ .
Â¦onlineÂ¦ Â¦cons um ersÂ¦ 
Â¦30Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦do ub lesÂ¦ Â¦downÂ¦ Â¦onÂ¦ Â¦prev eningÂ¦ Â¦sc a msÂ¦ Â¦andÂ¦ Â¦prot ectingÂ¦ Â¦cons um ersÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦comm it tedÂ¦ Â¦toÂ¦ Â¦prot ectingÂ¦ Â¦cons um ersÂ¦ Â¦onlineÂ¦ â–â€“â– Â¦especiallyÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦whereÂ¦ Â¦someÂ¦ Â¦r og ueÂ¦ Â¦a ctorsÂ¦ Â¦areÂ¦ Â¦pro mo tingÂ¦ Â¦f al seÂ¦ Â¦cl ai msÂ¦ Â¦orÂ¦ Â¦sc amÂ¦ Â¦produc tsÂ¦ .
Â¦we st er nÂ¦ Â¦b al k ansÂ¦ Â¦a idÂ¦ 
Â¦2 9Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦t ac k l ingÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦c ri sisÂ¦ :â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ste psÂ¦ Â¦upÂ¦ Â¦itsÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦we st er nÂ¦ ğ‹‡Â¦b al k ansÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦overÂ¦ â– â‚¬ Â¦3Â¦ .
ğ‹‡ Â¦v al di sÂ¦ ğ‹‡ Â¦do mb r ov s k i sÂ¦ ğ‹‡ Â¦pr essÂ¦ ğ‹‡ Â¦conf er enceÂ¦ 
Â¦2 8Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦b an kingÂ¦ Â¦p ac k ageÂ¦ :â– Â¦supp ortingÂ¦ Â¦hou se h ol dsÂ¦ Â¦andÂ¦ Â¦b us in es sesÂ¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦thatÂ¦ Â¦b an ksÂ¦ Â¦canÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦l endÂ¦ Â¦mo ne yÂ¦ ,â– Â¦supportÂ¦ Â¦theÂ¦ Â¦ec on om yÂ¦ Â¦andÂ¦ Â¦helpÂ¦ Â¦m it ig ateÂ¦ Â¦theÂ¦ Â¦ec onomicÂ¦ Â¦impac tsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ Â¦b an kingÂ¦ Â¦p ac k ageÂ¦ .
Â¦globalÂ¦ Â¦s um mi tÂ¦ 
Â¦2 7Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â–  Â¦la un chesÂ¦ Â¦globalÂ¦ Â¦pl ed gingÂ¦ Â¦eff ortÂ¦ Â¦withÂ¦ Â¦part n ersÂ¦
ğ‹‡Â¦toÂ¦ Â¦develop Â¦ Â¦andÂ¦ Â¦dep lo yÂ¦ Â¦safeÂ¦ ,â– Â¦effectiveÂ¦ Â¦andÂ¦ Â¦aff or d ableÂ¦ Â¦diagn o st icsÂ¦ ,â– Â¦ ther ap e ut icsÂ¦ Â¦andÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦un ionÂ¦ Â¦isÂ¦ Â¦j oi ningÂ¦ Â¦for cesÂ¦ Â¦withÂ¦ Â¦globalÂ¦ Â¦part n ersÂ¦ Â¦toÂ¦ Â¦k ickÂ¦ - Â¦star tÂ¦ Â¦aÂ¦ Â¦pl ed gingÂ¦ Â¦eff ortÂ¦ â–â€“â– Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦responseÂ¦ â–â€“â– Â¦star tingÂ¦ Â¦onÂ¦ Â¦4Â¦ ğ‹‡ Â¦mayÂ¦ Â¦2020Â¦ .
Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ Â¦v ide oÂ¦ Â¦conf er enceÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦toÂ¦ Â¦sh ap eÂ¦ Â¦aÂ¦ Â¦commonÂ¦ Â¦reco ve ryÂ¦ Â¦pl anÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦re v a mp edÂ¦  Â¦longÂ¦ - Â¦ter mÂ¦ Â¦b ud g etÂ¦ Â¦atÂ¦ Â¦itsÂ¦ Â¦h ear tÂ¦ â–
ğ‹‡ Â¦europeanÂ¦ Â¦lea d ersÂ¦ Â¦t as kedÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦withÂ¦ Â¦sh ap ingÂ¦ Â¦aÂ¦ Â¦coll ectiveÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦c ri sisÂ¦ Â¦followingÂ¦ Â¦aÂ¦ Â¦v ide oc on f er enceÂ¦ Â¦onÂ¦ Â¦23Â¦ ğ‹‡ Â¦aprilÂ¦ .
Â¦ag r ic ol t ureÂ¦ Â¦pr ogra mm esÂ¦ 
Â¦23Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦ex cep tionalÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦ag r ic ult uralÂ¦ Â¦foodÂ¦ Â¦s ectorÂ¦
ğ‹‡Â¦toÂ¦ Â¦sw if t lyÂ¦ Â¦supportÂ¦ Â¦ag r ic ult uralÂ¦ Â¦s ectorÂ¦ Â¦andÂ¦ Â¦foodÂ¦ Â¦mark etsÂ¦ Â¦followingÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦prop osedÂ¦ Â¦ex cep tionalÂ¦ Â¦measuresÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦gr antÂ¦ Â¦priv ateÂ¦ Â¦st or ageÂ¦ Â¦a idÂ¦ Â¦forÂ¦ Â¦d ai ryÂ¦ Â¦andÂ¦ Â¦me atÂ¦ Â¦produc tsÂ¦ ,â– Â¦f le xi bilityÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦imp le me nt ationÂ¦ Â¦ofÂ¦ Â¦mark etÂ¦ Â¦supportÂ¦ Â¦pr ogra mm esÂ¦ Â¦toÂ¦ Â¦ref oc usÂ¦ Â¦f un dingÂ¦ Â¦pri or itiesÂ¦ ,â– Â¦andÂ¦ Â¦ex cep tionalÂ¦ Â¦d er og ationÂ¦ Â¦fromÂ¦  Â¦comp et itionÂ¦ Â¦ ru lesÂ¦ Â¦toÂ¦ Â¦st ab il iseÂ¦ Â¦theÂ¦ Â¦mark etsÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦se ctorsÂ¦ .
 Â¦f la g sÂ¦ 
Â¦2 2Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– â‚¬ Â¦3Â¦ Â¦bi ll ionÂ¦ Â¦fi na nc ialÂ¦ Â¦ass ist anceÂ¦ Â¦p ac k ageÂ¦ Â¦forÂ¦ Â¦t enÂ¦ Â¦ne i gh bo ur ingÂ¦ Â¦countriesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop osedÂ¦ Â¦aÂ¦ â– â‚¬ Â¦3Â¦ Â¦bi ll ionÂ¦ Â¦m ac r oÂ¦ - Â¦fi na nc ialÂ¦ Â¦ass ist anceÂ¦ Â¦p ac k ageÂ¦ Â¦toÂ¦ Â¦t enÂ¦ Â¦en l ar ge mentÂ¦ Â¦andÂ¦ Â¦ne i gh bo ur h oodÂ¦ Â¦part n ersÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ ai mÂ¦ Â¦toÂ¦ Â¦limi tÂ¦ Â¦theÂ¦ Â¦ec onomicÂ¦ Â¦f al lo utÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦c ri sisÂ¦ Â¦inÂ¦ Â¦part n erÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦ im ageÂ¦ Â¦ofÂ¦ Â¦handsÂ¦ Â¦w earingÂ¦ Â¦g lo vesÂ¦ 
Â¦ 21Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â–  Â¦m ob i li sesÂ¦ Â¦supportÂ¦ Â¦forÂ¦ ğ‹‡ Â¦italyÂ¦ ,â– ğ‹‡Â¦c ro at iaÂ¦ Â¦andÂ¦ Â¦ne i gh bo ur ingÂ¦ Â¦countriesÂ¦
ğ‹‡Â¦theÂ¦  Â¦co or d in atesÂ¦ Â¦andÂ¦ Â¦c oÂ¦ - Â¦f in an cesÂ¦ Â¦theÂ¦ Â¦de li ve ryÂ¦ Â¦ofÂ¦ Â¦a idÂ¦ Â¦sh ip mentsÂ¦ Â¦inÂ¦ Â¦theÂ¦  Â¦andÂ¦ Â¦inÂ¦ Â¦ne i gh bo ur ingÂ¦ Â¦countriesÂ¦ ,â– Â¦afterÂ¦ Â¦re qu e stsÂ¦ Â¦forÂ¦ Â¦ass ist anceÂ¦ Â¦v iaÂ¦ Â¦theÂ¦  ğ‹‡Â¦c iv ilÂ¦ ğ‹‡ Â¦prote ctionÂ¦ ğ‹‡ Â¦me ch an is mÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦f ightÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦ im ageÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦ser verÂ¦ Â¦ro omÂ¦ 
Â¦20Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦coronavirusÂ¦ :â– ğ‹‡ Â¦newÂ¦ Â¦dataÂ¦ Â¦sh ar ingÂ¦ Â¦pl at for mÂ¦ Â¦forÂ¦ Â¦res ear ch ersÂ¦
ğ‹‡ Â¦anÂ¦   - Â¦19Â¦ ğ‹‡ Â¦dataÂ¦ ğ‹‡ Â¦pl at for mÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦ es ta bl ishedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦andÂ¦ Â¦part n ersÂ¦ Â¦toÂ¦ Â¦rap id lyÂ¦ Â¦coll ectÂ¦ Â¦andÂ¦ Â¦shareÂ¦ Â¦comp re he ns iveÂ¦ Â¦coronavirusÂ¦ Â¦researchÂ¦ Â¦dataÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦  Â¦se qu en cesÂ¦ ,â– Â¦proteinÂ¦ Â¦st ru ct uresÂ¦ ,â– Â¦dataÂ¦ Â¦fromÂ¦ Â¦pr eÂ¦ - Â¦clinicalÂ¦ Â¦researchÂ¦ Â¦andÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦e p ide mi ologicalÂ¦ Â¦dataÂ¦ ,â– Â¦toÂ¦ Â¦ad v anceÂ¦ Â¦researchÂ¦ Â¦eff ortsÂ¦ .
Â¦p as se ngerÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦air p ortÂ¦ 
Â¦1 7Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦overÂ¦ Â¦5 00Â¦ , Â¦000Â¦  Â¦c itiz ensÂ¦ Â¦br ou gh tÂ¦ Â¦homeÂ¦
ğ‹‡Â¦theÂ¦  Â¦hasÂ¦ Â¦mana gedÂ¦ Â¦toÂ¦ Â¦br ingÂ¦ Â¦homeÂ¦ Â¦overÂ¦ Â¦h al fÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦c itiz ensÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦coronavirusÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦byÂ¦ Â¦f un dingÂ¦ Â¦rep at ri ationÂ¦ Â¦f li gh tsÂ¦ Â¦andÂ¦ Â¦c arr yingÂ¦ Â¦outÂ¦ Â¦int en seÂ¦ Â¦cons ularÂ¦ Â¦co op er ationÂ¦ .
Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ Â¦pr essÂ¦ Â¦conf er enceÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦aprilÂ¦ â–â€“â– Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ :â– â€œ ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦b ud g etÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦theÂ¦ Â¦mo ther s hi pÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur opeÂ¦ â€™ Â¦sÂ¦ Â¦reco ve ryÂ¦ â€
ğ‹‡Â¦d esp iteÂ¦ ğ‹‡Â¦e ur opeÂ¦ â€™ Â¦sÂ¦ Â¦coll ectiveÂ¦ Â¦responseÂ¦ Â¦beingÂ¦ Â¦wellÂ¦ Â¦a bo veÂ¦ â– â‚¬ Â¦3Â¦ Â¦t ri ll ionÂ¦ â–â€“â– Â¦theÂ¦ Â¦mostÂ¦ Â¦imp re ss iveÂ¦ Â¦responseÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦worldÂ¦ â–-â– Â¦moreÂ¦ Â¦isÂ¦ Â¦nee dedÂ¦ ,â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ .
Â¦wom anÂ¦ Â¦h ol dingÂ¦ Â¦ herÂ¦ Â¦phoneÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦aprilÂ¦ â–â€“â– Â¦2020Â¦ â–â€“â– ğ‹‡Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦appro a chÂ¦ Â¦toÂ¦ Â¦trac ingÂ¦ Â¦app sÂ¦ â–â€“â– Â¦comp le telyÂ¦ Â¦v o lu nt aryÂ¦ Â¦andÂ¦ Â¦f ul lyÂ¦ Â¦resp ectingÂ¦ Â¦priv acyÂ¦
ğ‹‡Â¦toÂ¦ Â¦ es ta bl ishÂ¦ Â¦v o lu nt aryÂ¦ Â¦contactÂ¦ Â¦trac ingÂ¦ Â¦andÂ¦ Â¦w ar ningÂ¦ Â¦sys temsÂ¦ Â¦thatÂ¦ Â¦f ul lyÂ¦ Â¦resp ectÂ¦ Â¦priv acyÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦p utÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦to ol bo xÂ¦ Â¦andÂ¦ Â¦gu id el inesÂ¦ .
Â¦ch ar lesÂ¦ Â¦mi che lÂ¦ Â¦andÂ¦ Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ Â¦le y enÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦ro a d ma pÂ¦ Â¦toÂ¦ Â¦l if tingÂ¦ Â¦conta in mentÂ¦ Â¦measuresÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ ,â– Â¦inÂ¦ Â¦co op er ationÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦p utÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦ro a d ma pÂ¦ ,â– Â¦recomm end ationsÂ¦ Â¦andÂ¦ Â¦k e yÂ¦ Â¦pri nc ip lesÂ¦ Â¦toÂ¦ Â¦l if tingÂ¦ Â¦theÂ¦ Â¦conta in mentÂ¦ Â¦measuresÂ¦ .
ğ‹‡ Â¦prot ectiveÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– â‚¬ Â¦2Â¦ , Â¦7Â¦ Â¦bi ll ionÂ¦ Â¦fromÂ¦ Â¦theÂ¦  Â¦b ud g etÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦healthcareÂ¦ Â¦s ectorÂ¦
ğ‹‡Â¦toÂ¦ Â¦dir ect lyÂ¦ Â¦supportÂ¦ Â¦healthcareÂ¦ Â¦sys temsÂ¦ Â¦inÂ¦  Â¦countriesÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop osedÂ¦ Â¦toÂ¦ Â¦activ ateÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ ğ‹‡ Â¦emergencyÂ¦ ğ‹‡ Â¦supportÂ¦ ğ‹‡ Â¦inst ru mentÂ¦ â–â€“â– Â¦aÂ¦ Â¦me as ureÂ¦ Â¦thatÂ¦ Â¦thatÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦qu ick lyÂ¦ Â¦appr ovedÂ¦ Â¦onÂ¦ Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ .
Â¦p i llsÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– â‚¬ Â¦15Â¦ . Â¦6Â¦ Â¦bi ll ionÂ¦ Â¦forÂ¦ Â¦globalÂ¦  Â¦coronavirusÂ¦ Â¦responseÂ¦ ;â–  Â¦ca llsÂ¦ Â¦onÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦a v ai la bilityÂ¦ Â¦ofÂ¦ Â¦medic inesÂ¦
ğ‹‡Â¦toÂ¦ Â¦f ightÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦gl ob eÂ¦ ,â– Â¦theÂ¦  Â¦willÂ¦ Â¦supportÂ¦ Â¦theÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦andÂ¦ Â¦ad dr essÂ¦ Â¦theÂ¦ Â¦h um an i ta ri anÂ¦ Â¦andÂ¦ Â¦s an it aryÂ¦ Â¦needsÂ¦ Â¦ofÂ¦ Â¦part n erÂ¦ Â¦countriesÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦gl ob eÂ¦ Â¦byÂ¦ Â¦provid ingÂ¦ Â¦fi na nc ialÂ¦ Â¦ass ist anceÂ¦ Â¦ofÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ â– â‚¬ Â¦15Â¦ .
Â¦coronavirusÂ¦ Â¦medicalÂ¦ Â¦uni tÂ¦ 
Â¦0 7Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â–  ğ‹‡ Â¦medicalÂ¦ ğ‹‡ Â¦cor psÂ¦ Â¦dep lo y edÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦
ğ‹‡ Â¦to dayÂ¦ ,â– Â¦theÂ¦  ğ‹‡ Â¦medicalÂ¦ ğ‹‡ Â¦cor psÂ¦ Â¦co or d in atedÂ¦ Â¦byÂ¦ Â¦theÂ¦  ğ‹‡ Â¦emergencyÂ¦ ğ‹‡ Â¦responseÂ¦ ğ‹‡ Â¦co or d inationÂ¦ ğ‹‡ Â¦centreÂ¦ Â¦dis p at chedÂ¦ Â¦aÂ¦ Â¦teamÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦do ctorsÂ¦ Â¦andÂ¦ Â¦n ur sesÂ¦ Â¦fromÂ¦ ğ‹‡ Â¦r om an iaÂ¦ Â¦andÂ¦ ğ‹‡Â¦n or w ayÂ¦ Â¦toÂ¦ ğ‹‡Â¦b er g a m oÂ¦ .
ğ‹‡ Â¦fi na nc ialÂ¦ Â¦a idÂ¦ Â¦coronavirusÂ¦ 
Â¦0 6Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– â‚¬ Â¦8Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦someÂ¦ Â¦100Â¦ , Â¦000Â¦ ğ‹‡ Â¦europeanÂ¦ Â¦b us in es sesÂ¦
ğ‹‡Â¦f un dingÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦andÂ¦ Â¦provideÂ¦ Â¦rel iefÂ¦ Â¦toÂ¦ Â¦someÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦b us in es sesÂ¦ Â¦hi tÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦ec onomicÂ¦ Â¦con se qu en cesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦availableÂ¦ Â¦inÂ¦ ğ‹‡ Â¦aprilÂ¦ Â¦asÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦in ve st mentÂ¦ ğ‹‡Â¦f un dÂ¦ Â¦un l oc kÂ¦ â– â‚¬ Â¦8Â¦ Â¦bi ll ionÂ¦ Â¦fromÂ¦ Â¦th an ksÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦f un dÂ¦ Â¦forÂ¦ ğ‹‡ Â¦stra te g icÂ¦ ğ‹‡ Â¦in ve st mentsÂ¦ .
Â¦workersÂ¦ Â¦produc ingÂ¦ Â¦masksÂ¦ 
Â¦0 3Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦po st p o ningÂ¦ Â¦regul ationÂ¦ Â¦forÂ¦ Â¦medicalÂ¦ Â¦de vi cesÂ¦ ,â– Â¦l if tingÂ¦ Â¦c u st o msÂ¦ Â¦d ut iesÂ¦ Â¦forÂ¦ Â¦prot ectiveÂ¦ Â¦equipmentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop osedÂ¦ Â¦toÂ¦ Â¦po st p oneÂ¦ Â¦regul ationsÂ¦ Â¦onÂ¦ Â¦medicalÂ¦ Â¦de vi cesÂ¦ Â¦byÂ¦ Â¦oneÂ¦ Â¦yearÂ¦ Â¦toÂ¦ Â¦all owÂ¦ Â¦m an u fa ct ur ersÂ¦ Â¦toÂ¦ Â¦f oc usÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦produc t ionÂ¦ Â¦ofÂ¦ Â¦crit icalÂ¦ Â¦medicalÂ¦ Â¦de vi cesÂ¦ Â¦andÂ¦ Â¦a v oi dingÂ¦ Â¦sh or ta gesÂ¦ Â¦orÂ¦ Â¦del aysÂ¦ Â¦pote nt iallyÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦regul atoryÂ¦ Â¦ bo diesÂ¦ ,â– Â¦the re b yÂ¦ Â¦andÂ¦ Â¦sa vingÂ¦ Â¦l ivesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦alsoÂ¦ Â¦dec i dedÂ¦ Â¦toÂ¦ Â¦temp o ra ri lyÂ¦ Â¦l if tÂ¦ Â¦c u st o msÂ¦ Â¦d ut iesÂ¦ Â¦andÂ¦  Â¦onÂ¦ Â¦theÂ¦ Â¦imp ortÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦de vi cesÂ¦ Â¦andÂ¦ Â¦prot ectiveÂ¦ Â¦equipmentÂ¦ Â¦fromÂ¦ Â¦thir dÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ 
Â¦0 2Â¦ ğ‹‡ Â¦aprilÂ¦ â–-â– ğ‹‡ Â¦coronavirusÂ¦ Â¦responseÂ¦ :â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦m ob i li sesÂ¦ Â¦everyÂ¦ Â¦e ur oÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦l ivesÂ¦ Â¦andÂ¦ Â¦li ve li h oo dsÂ¦
ğ‹‡Â¦toÂ¦ Â¦qu ick lyÂ¦ Â¦supportÂ¦ Â¦workersÂ¦ Â¦andÂ¦ Â¦m it ig ateÂ¦ Â¦theÂ¦ Â¦u ne mploy mentÂ¦ Â¦r is ksÂ¦ Â¦thatÂ¦ Â¦comeÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦outbreakÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦la un chedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦in i ti ativeÂ¦ Â¦calledÂ¦  â–-â– ğ‹‡ Â¦supportÂ¦ Â¦m it ig atingÂ¦ ğ‹‡ Â¦u ne mploy mentÂ¦ ğ‹‡ Â¦r is ksÂ¦ Â¦inÂ¦ ğ‹‡ Â¦emergencyÂ¦ .
Â¦sc ie nt istÂ¦ 
Â¦0 1Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦sc ien ti stsÂ¦ Â¦develop Â¦ Â¦newÂ¦ Â¦controlÂ¦ Â¦m at er ialÂ¦ Â¦forÂ¦ Â¦re li ableÂ¦ ğ‹‡ Â¦coronavirusÂ¦ - Â¦testingÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ 
ğ‹‡ Â¦sc ien ti stsÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦haveÂ¦ Â¦d es ig nedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦controlÂ¦ Â¦m at er ialÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦acc u ra telyÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ Â¦f u nc tion ingÂ¦ Â¦ofÂ¦ Â¦theirÂ¦ Â¦coronavirusÂ¦ Â¦testsÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦f al seÂ¦ Â¦ne g at ivesÂ¦ .
Â¦la wÂ¦ 
Â¦3 1Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦w ar nsÂ¦ :â– ğ‹‡ Â¦emergencyÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦measuresÂ¦ Â¦mustÂ¦ Â¦resp ectÂ¦  Â¦f u nd a me ntalÂ¦ Â¦pri nc ip lesÂ¦ Â¦andÂ¦ Â¦v al uesÂ¦
ğ‹‡ Â¦overÂ¦ Â¦theÂ¦ Â¦p astÂ¦ Â¦weeksÂ¦ ,â– Â¦severalÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦haveÂ¦ Â¦ta k enÂ¦ Â¦emergencyÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦ad dr essÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦c ri sisÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦outbreakÂ¦ .
Â¦30Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2020Â¦ â–â€“â– Â¦la un chÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦d ed ic atedÂ¦ â– â€˜ ğ‹‡ Â¦fi gh tingÂ¦ Â¦disinf orm ationÂ¦ â€™ â– Â¦se ctionÂ¦ Â¦l in kedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦outbreakÂ¦
ğ‹‡Â¦m is in f orm ationÂ¦ Â¦andÂ¦ Â¦disinf orm ationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦sp aceÂ¦ Â¦areÂ¦ Â¦th ri vingÂ¦ ,â– Â¦includingÂ¦ Â¦onÂ¦  - Â¦19Â¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦importantÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦r elyÂ¦ Â¦onlyÂ¦ Â¦onÂ¦ Â¦author it ativeÂ¦ Â¦sour cesÂ¦ Â¦toÂ¦ Â¦getÂ¦ Â¦up d atedÂ¦ Â¦informationÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦co or d in atingÂ¦ Â¦aÂ¦ Â¦commonÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦hasÂ¦ Â¦ es ta bl ishedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦responseÂ¦ Â¦teamÂ¦ Â¦atÂ¦ Â¦pol it icalÂ¦ Â¦levelÂ¦ Â¦toÂ¦ Â¦co or d in ateÂ¦ Â¦ourÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦
ğ‹‡ Â¦duringÂ¦ Â¦theseÂ¦ Â¦timesÂ¦ Â¦ofÂ¦ Â¦c ri sisÂ¦ ,â– Â¦acrossÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦un ionÂ¦ ,â– Â¦countriesÂ¦ ,â– Â¦regi onsÂ¦ Â¦andÂ¦ Â¦c itiesÂ¦ Â¦areÂ¦ Â¦ str et c hingÂ¦ Â¦outÂ¦ Â¦aÂ¦ Â¦h el p ingÂ¦ Â¦handÂ¦ Â¦toÂ¦ Â¦ne i gh bo ur sÂ¦ Â¦andÂ¦ Â¦ass ist anceÂ¦ Â¦isÂ¦ Â¦giv enÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦mostÂ¦ Â¦inÂ¦ Â¦needÂ¦ :â– Â¦d on ationsÂ¦ Â¦ofÂ¦ Â¦prot ectiveÂ¦ Â¦equipmentÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦masksÂ¦ ,â– Â¦c rossÂ¦ - Â¦ bor derÂ¦ Â¦tre at mentsÂ¦ Â¦ofÂ¦ Â¦ illÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦bringingÂ¦ Â¦stra ndedÂ¦ Â¦c itiz ensÂ¦ Â¦homeÂ¦ .
ğ‹‡ Â¦safeÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur op e ansÂ¦
ğ‹‡Â¦aÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦ourÂ¦ Â¦b estÂ¦ Â¦ch anceÂ¦ Â¦toÂ¦ Â¦be atÂ¦ Â¦coronavirusÂ¦ Â¦andÂ¦ Â¦retur nÂ¦ Â¦toÂ¦ Â¦ourÂ¦ Â¦normalÂ¦ Â¦l ivesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦wor kingÂ¦ Â¦ti re le ss lyÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦pote ntialÂ¦ Â¦vaccinesÂ¦ ,â– Â¦thatÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦sh aredÂ¦ Â¦withÂ¦ Â¦allÂ¦ .
Â¦4Â¦ ğ‹‡ Â¦juneÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦  Â¦prop o sesÂ¦ Â¦aÂ¦ Â¦st ro ngÂ¦ Â¦mult il at er alÂ¦ Â¦tra deÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦theÂ¦  Â¦hasÂ¦ Â¦sub m it tedÂ¦ Â¦itsÂ¦ Â¦prop os alÂ¦ Â¦s ee kingÂ¦ Â¦theÂ¦ Â¦comm it mentÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦worldÂ¦ ğ‹‡ Â¦tra deÂ¦ ğ‹‡ Â¦organiz ationÂ¦ Â¦me mbersÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦mult il at er alÂ¦ Â¦tra deÂ¦ Â¦a ctionÂ¦ Â¦pl anÂ¦ Â¦toÂ¦ Â¦exp andÂ¦ Â¦theÂ¦ Â¦produc t ionÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦andÂ¦ Â¦tre at mentsÂ¦ .
Â¦m anÂ¦ Â¦h ol dingÂ¦ Â¦aÂ¦ Â¦lea f l etÂ¦ 
Â¦ 21Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦author i sesÂ¦ Â¦firstÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mark e tingÂ¦ Â¦author is ationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  â€‘ Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦  Â¦andÂ¦ ğ‹‡Â¦p f iz erÂ¦ .
Â¦vaccineÂ¦ 
Â¦1 7Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦an no un cesÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦vacc inationÂ¦ Â¦daysÂ¦ Â¦onÂ¦ Â¦2 7Â¦ ,â– Â¦2 8Â¦ Â¦andÂ¦ Â¦2 9Â¦ ğ‹‡ Â¦decemberÂ¦
ğ‹‡Â¦inÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦s uc cess fulÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦author is ationÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦medic inesÂ¦ ğ‹‡ Â¦a ge ncyÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ ,â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦onÂ¦ Â¦2 7Â¦ ,â– Â¦2 8Â¦ Â¦andÂ¦ Â¦2 9Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦vacc inationÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦willÂ¦ Â¦star tÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  .
Â¦wom anÂ¦ Â¦inÂ¦ Â¦f r on tÂ¦ Â¦ofÂ¦  Â¦comm i ssionÂ¦ Â¦bu il dingÂ¦ Â¦l oo kingÂ¦ Â¦atÂ¦ Â¦ herÂ¦ Â¦s ma rt ph oneÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦la un chesÂ¦ ğ‹‡ Â¦r eÂ¦ - Â¦openÂ¦  Â¦m ob i leÂ¦ Â¦appÂ¦ Â¦withÂ¦ Â¦reg ularÂ¦ Â¦up d atesÂ¦ Â¦onÂ¦ Â¦coronavirusÂ¦ Â¦healthÂ¦ ,â– Â¦safetyÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦measuresÂ¦ Â¦acrossÂ¦ ğ‹‡Â¦e ur opeÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦la un chedÂ¦ Â¦theÂ¦ Â¦fre eÂ¦ ğ‹‡ Â¦r eÂ¦ - Â¦openÂ¦  Â¦m ob i leÂ¦ Â¦appÂ¦ ,â– Â¦provid ingÂ¦ Â¦comp re he ns iveÂ¦ ,â– Â¦upÂ¦ - Â¦toÂ¦ - Â¦dateÂ¦ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthÂ¦ ,â– Â¦safetyÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦measuresÂ¦ Â¦inÂ¦ Â¦allÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦andÂ¦ ğ‹‡ Â¦i ce landÂ¦ ,â– ğ‹‡Â¦l ie ch tens te inÂ¦ ,â– ğ‹‡Â¦n or w ayÂ¦ Â¦andÂ¦ ğ‹‡ Â¦sw it z er landÂ¦ .
ğ‹‡ Â¦europeanÂ¦ Â¦dem oc r acyÂ¦ Â¦a ctionÂ¦ Â¦pl anÂ¦ 
Â¦3Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦dem oc r acyÂ¦ ğ‹‡ Â¦a ctionÂ¦ ğ‹‡ Â¦pl anÂ¦ :â– Â¦ma kingÂ¦  Â¦dem oc r ac iesÂ¦ Â¦st ro ngerÂ¦
ğ‹‡Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ Â¦hasÂ¦ Â¦high li gh tedÂ¦ Â¦cha ll en gesÂ¦ Â¦toÂ¦ Â¦theÂ¦  Â¦dem oc r ac iesÂ¦ .
ğ‹‡ Â¦maskÂ¦ Â¦andÂ¦  Â¦f la gÂ¦ 
Â¦2Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entsÂ¦ â– â€œ ğ‹‡ Â¦sta yingÂ¦ Â¦safeÂ¦ Â¦fromÂ¦  - Â¦19Â¦ Â¦duringÂ¦ Â¦w in terÂ¦ â€ â– Â¦stra te g yÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ Â¦stra te g yÂ¦ Â¦forÂ¦ Â¦s us ta in ab lyÂ¦ Â¦mana gingÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦c om ingÂ¦ Â¦w in terÂ¦ Â¦mon thsÂ¦ ,â– Â¦whenÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦transmissionÂ¦ Â¦riskÂ¦ Â¦mayÂ¦ Â¦increaseÂ¦ Â¦ owingÂ¦ Â¦toÂ¦ Â¦in doorÂ¦ Â¦ga ther ingsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦stra te g yÂ¦ Â¦recomm endsÂ¦ Â¦contin u edÂ¦ Â¦v ig il anceÂ¦ Â¦andÂ¦ Â¦ca utionÂ¦ Â¦th r ou g ho utÂ¦ Â¦theÂ¦ Â¦w in terÂ¦ Â¦periodÂ¦ Â¦andÂ¦ Â¦intoÂ¦ Â¦2021Â¦ Â¦whenÂ¦ Â¦theÂ¦ Â¦r ol lÂ¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccinesÂ¦ Â¦willÂ¦ Â¦occur Â¦ .
ğ‹‡Â¦aÂ¦ Â¦co or d in atedÂ¦  - Â¦w ideÂ¦ Â¦appro a chÂ¦ Â¦isÂ¦ Â¦k e yÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦aÂ¦ Â¦res ur g enceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ ,â– Â¦andÂ¦ Â¦anyÂ¦ Â¦re la x ationÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦shouldÂ¦ Â¦takeÂ¦ Â¦intoÂ¦ Â¦acc o un tÂ¦ Â¦theÂ¦ Â¦ev ol utionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦e p ide mi ologicalÂ¦ Â¦s itu ationÂ¦ .
Â¦1Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sesÂ¦ â– â‚¬ Â¦8Â¦ . Â¦5Â¦ Â¦bi ll ionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦fiveÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦s us tainÂ¦ Â¦j ob sÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦dis b ur sedÂ¦ â– â‚¬ Â¦8Â¦ .
ğ‹‡ Â¦ph arm aÂ¦ Â¦stra te g yÂ¦ 
Â¦2 5Â¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦ph ar ma ce ut icalÂ¦ ğ‹‡ Â¦stra te g yÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ :â– Â¦aff or d ableÂ¦ ,â– Â¦acc es si bleÂ¦ Â¦andÂ¦ Â¦safeÂ¦ Â¦medic inesÂ¦ Â¦forÂ¦ Â¦allÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦ph ar ma ce ut icalÂ¦ ğ‹‡ Â¦stra te g yÂ¦ Â¦forÂ¦ ğ‹‡Â¦e ur opeÂ¦ Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦thatÂ¦ Â¦e veryoneÂ¦ Â¦willÂ¦ Â¦haveÂ¦ Â¦acc essÂ¦ Â¦toÂ¦ Â¦in n ov ativeÂ¦ Â¦andÂ¦ Â¦aff or d ableÂ¦ Â¦medic inesÂ¦ Â¦whileÂ¦ Â¦supp ortingÂ¦ Â¦comp e ti ti ve nessÂ¦ ,â– Â¦in n ov ationÂ¦ Â¦andÂ¦ Â¦su st ai na bilityÂ¦ Â¦ofÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦ind u st ryÂ¦ .
ğ‹‡ Â¦rap idÂ¦ Â¦testsÂ¦ 
Â¦18Â¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ste psÂ¦ Â¦upÂ¦ Â¦ac tionsÂ¦ Â¦onÂ¦ Â¦testingÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦recomm end ationÂ¦ Â¦onÂ¦ Â¦rap idÂ¦ Â¦anti g enÂ¦ Â¦testsÂ¦ Â¦andÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦increaseÂ¦ Â¦testingÂ¦ Â¦c ap ac ityÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ Â¦recomm end ationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦rap idÂ¦ Â¦anti g enÂ¦ Â¦testsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diagn o sisÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ ai mÂ¦ Â¦ofÂ¦ Â¦e ns ur ingÂ¦ Â¦theÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦ofÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦sm oo thÂ¦ Â¦f u nc tion ingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦inter n alÂ¦ Â¦mark etÂ¦ 
Â¦1 7Â¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sesÂ¦ â– â‚¬ Â¦14Â¦ Â¦bi ll ionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦n ineÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦s us tainÂ¦ Â¦j ob sÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦dis b ur sedÂ¦ â– â‚¬ Â¦14Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ Â¦n ineÂ¦  Â¦countriesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦secondÂ¦ Â¦inst al mentÂ¦ Â¦ofÂ¦ Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦underÂ¦ Â¦theÂ¦  Â¦inst ru mentÂ¦ .
ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦healthÂ¦ ğ‹‡ Â¦un ionÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦ta k esÂ¦ Â¦firstÂ¦ Â¦ste psÂ¦ Â¦t ow ardsÂ¦ Â¦bu il dingÂ¦ Â¦aÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦healthÂ¦ ğ‹‡ Â¦un ionÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦p ut tingÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦s etÂ¦ Â¦ofÂ¦ Â¦prop os alsÂ¦ Â¦toÂ¦ Â¦st re ng th enÂ¦ Â¦theÂ¦  ' Â¦sÂ¦ Â¦healthÂ¦ Â¦sec ur ityÂ¦ Â¦fra me w or kÂ¦ ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦re in for ceÂ¦ Â¦theÂ¦ Â¦c ri sisÂ¦ Â¦pre par ed nessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦ro leÂ¦ Â¦ofÂ¦ Â¦k e yÂ¦  Â¦a ge nc iesÂ¦ .
 
Â¦10Â¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦w el c omesÂ¦ Â¦ag r ee mentÂ¦ Â¦onÂ¦ â– â‚¬ Â¦1Â¦ . Â¦8Â¦ Â¦t ri ll ionÂ¦  Â¦longÂ¦ - Â¦ter mÂ¦ Â¦b ud g etÂ¦ Â¦andÂ¦  Â¦toÂ¦ Â¦helpÂ¦ Â¦bu i ldÂ¦ Â¦g re en erÂ¦ ,â– Â¦moreÂ¦ Â¦d ig it alÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦re si li entÂ¦ ğ‹‡Â¦e ur opeÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ Â¦andÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦haveÂ¦ Â¦ag re edÂ¦ Â¦onÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ Â¦longÂ¦ - Â¦ter mÂ¦ Â¦b ud g etÂ¦ Â¦andÂ¦  .
ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦ Â¦f ig uresÂ¦ 
Â¦5Â¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦a ut um nÂ¦ Â¦2020Â¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦
ğ‹‡Â¦theÂ¦ Â¦ec onomicÂ¦ Â¦impac tÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦hasÂ¦ Â¦di ff eredÂ¦ Â¦wid elyÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  .
Â¦wom anÂ¦ Â¦h ol dingÂ¦ Â¦aÂ¦ Â¦phoneÂ¦ 
Â¦2 8Â¦ ğ‹‡ Â¦o ct ob erÂ¦ â–â€“â– ğ‹‡Â¦t ac k l ingÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦res ur g enceÂ¦ :â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦s etsÂ¦ Â¦outÂ¦ Â¦newÂ¦ Â¦ac tionsÂ¦ Â¦toÂ¦ Â¦re in for ceÂ¦ Â¦pre par ed nessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦s etÂ¦ Â¦outÂ¦ Â¦co nc r et eÂ¦ Â¦ac tionsÂ¦ Â¦inÂ¦ Â¦aÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ Â¦onÂ¦ Â¦ad di tionalÂ¦  - Â¦19Â¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦limi tÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦sa veÂ¦ Â¦l ivesÂ¦ Â¦andÂ¦ Â¦bu i ldÂ¦ Â¦increasedÂ¦ Â¦re si li enceÂ¦ Â¦acrossÂ¦ Â¦severalÂ¦ Â¦areasÂ¦ Â¦inÂ¦ Â¦allÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ .
ğ‹‡ Â¦firstÂ¦ Â¦dis b ur se mentsÂ¦ Â¦underÂ¦  Â¦fi na nc ialÂ¦ Â¦supportÂ¦ 
Â¦2 7Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sesÂ¦ Â¦aÂ¦ Â¦firstÂ¦ â– â‚¬ Â¦1 7Â¦ Â¦bi ll ionÂ¦  Â¦inst al mentsÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦ ,â– ğ‹‡Â¦s pa inÂ¦ Â¦andÂ¦ ğ‹‡ Â¦po landÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sedÂ¦ Â¦aÂ¦ Â¦totalÂ¦ Â¦ofÂ¦ â– â‚¬ Â¦1 7Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ ğ‹‡ Â¦italyÂ¦ â–( â‚¬ Â¦10Â¦ Â¦bi ll ionÂ¦ ),â– ğ‹‡Â¦s pa inÂ¦ â–( â‚¬ Â¦6Â¦ Â¦bi ll ionÂ¦ )â– Â¦andÂ¦ ğ‹‡ Â¦po landÂ¦ â–( â‚¬ Â¦1Â¦ Â¦bi ll ionÂ¦ )â– Â¦inÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦inst al mentÂ¦ Â¦ofÂ¦  Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ .
Â¦m anÂ¦ Â¦l oo kingÂ¦ Â¦atÂ¦ Â¦s ma rt ph oneÂ¦ Â¦inÂ¦  
Â¦19Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–-â–  Â¦inter op e ra bilityÂ¦ Â¦ga te w ayÂ¦ Â¦go esÂ¦ Â¦liveÂ¦ ,â– Â¦firstÂ¦ Â¦contactÂ¦ Â¦trac ingÂ¦ Â¦andÂ¦ Â¦w ar ningÂ¦ Â¦app sÂ¦ Â¦l in kedÂ¦ Â¦toÂ¦ Â¦theÂ¦  - Â¦systemÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ ,â– Â¦atÂ¦ Â¦theÂ¦ Â¦inv it ationÂ¦ Â¦byÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ ,â– Â¦hasÂ¦ Â¦s etÂ¦ Â¦upÂ¦ Â¦anÂ¦  - Â¦w ideÂ¦ Â¦systemÂ¦ Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦thatÂ¦ Â¦coronavirusÂ¦ Â¦contactÂ¦ Â¦andÂ¦ Â¦trac ingÂ¦ Â¦app sÂ¦ Â¦canÂ¦ â– â€˜ Â¦t alkÂ¦ Â¦toÂ¦ Â¦eachÂ¦ Â¦otherÂ¦ â€™ .
ğ‹‡Â¦aÂ¦ Â¦sc ie nt istÂ¦ Â¦wor kingÂ¦ Â¦atÂ¦ Â¦aÂ¦ Â¦scre enÂ¦ 
Â¦15Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–â€“â–  Â¦vaccineÂ¦ Â¦stra te g yÂ¦ :â– Â¦pre par ed nessÂ¦ Â¦forÂ¦  - Â¦19Â¦ Â¦vacc inationÂ¦ Â¦stra te g iesÂ¦ Â¦andÂ¦ Â¦vaccineÂ¦ Â¦dep lo y mentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦publ ishedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ Â¦onÂ¦ Â¦pre par ed nessÂ¦ Â¦forÂ¦  - Â¦19Â¦ Â¦vacc inationÂ¦ Â¦stra te g iesÂ¦ Â¦andÂ¦ Â¦vaccineÂ¦ Â¦dep lo y mentÂ¦ .
Â¦twoÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦lu gg ageÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦tra inÂ¦ Â¦st ationÂ¦ 
Â¦13Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦ag r ee mentÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦co or d in atedÂ¦ Â¦appro a chÂ¦ Â¦toÂ¦ Â¦measuresÂ¦ Â¦re stric tingÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦inÂ¦ Â¦theÂ¦  Â¦inÂ¦ Â¦v ie wÂ¦ Â¦ofÂ¦  - Â¦19Â¦
 ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦haveÂ¦ Â¦ag re edÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦co or d in atedÂ¦ Â¦appro a chÂ¦ Â¦toÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦l in kedÂ¦ Â¦toÂ¦ Â¦theÂ¦  - Â¦19Â¦ Â¦pandemicÂ¦ .
ğ‹‡ Â¦moreÂ¦ Â¦informationÂ¦
Â¦13Â¦ ğ‹‡ Â¦bi ll ionÂ¦ Â¦f ig ureÂ¦ Â¦ ic onÂ¦ Â¦forÂ¦  
Â¦12Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡ Â¦firstÂ¦ Â¦resultsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦imp le me nt ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦responseÂ¦ ğ‹‡ Â¦in ve st mentÂ¦ ğ‹‡ Â¦in i ti at ivesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦rel ea sedÂ¦ Â¦theÂ¦ Â¦pro vi si on alÂ¦ Â¦firstÂ¦ Â¦resultsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦responseÂ¦ ğ‹‡ Â¦in ve st mentÂ¦ ğ‹‡ Â¦in i ti at ivesÂ¦ :â– Â¦theÂ¦  Â¦m ob i li sedÂ¦ Â¦overÂ¦ â– â‚¬ Â¦13Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ Â¦t ac k leÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
 - Â¦19Â¦ 
Â¦8Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦appro vesÂ¦ Â¦thir dÂ¦ Â¦contr ac tÂ¦ Â¦forÂ¦ Â¦pote ntialÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ Â¦andÂ¦ Â¦signsÂ¦ ğ‹‡ Â¦rem de si vi rÂ¦ Â¦de alÂ¦
ğ‹‡Â¦onÂ¦ Â¦7Â¦ ğ‹‡ Â¦o ct ob erÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦appr ovedÂ¦ Â¦aÂ¦ Â¦thir dÂ¦ Â¦contr ac tÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an yÂ¦ ,â– ğ‹‡ Â¦j an ss enÂ¦ ğ‹‡ Â¦ph ar ma ce ut icaÂ¦  ,â– Â¦forÂ¦ Â¦vaccineÂ¦ Â¦dosesÂ¦ Â¦forÂ¦ Â¦2 00Â¦ Â¦millionÂ¦ Â¦peopleÂ¦ .
Â¦st oc kÂ¦ Â¦nu mbersÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦toÂ¦ Â¦i ss ueÂ¦   Â¦b on dsÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ â– â‚¬ Â¦100Â¦ Â¦bi ll ionÂ¦ Â¦asÂ¦ Â¦socialÂ¦ Â¦b on dsÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦willÂ¦ Â¦i ss ueÂ¦   Â¦socialÂ¦ Â¦b on dsÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ â– â‚¬ Â¦100Â¦ Â¦bi ll ionÂ¦ Â¦andÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦ad op tedÂ¦ Â¦anÂ¦ Â¦in de p en de ntlyÂ¦ Â¦ev a lu atedÂ¦ ğ‹‡ Â¦socialÂ¦ ğ‹‡Â¦b on dÂ¦ ğ‹‡ Â¦fra me w or kÂ¦ .
ğ‹‡Â¦ ru leÂ¦ Â¦ofÂ¦ Â¦la wÂ¦ Â¦reportÂ¦ 
Â¦30Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦un ve il sÂ¦ Â¦firstÂ¦ - Â¦e verÂ¦ Â¦ ru leÂ¦ Â¦ofÂ¦ Â¦la wÂ¦ Â¦reportÂ¦ :â– Â¦coronavirusÂ¦ Â¦emergencyÂ¦ Â¦measuresÂ¦ Â¦mustÂ¦ Â¦resp ectÂ¦  â€™ Â¦sÂ¦ Â¦f u nd a me ntalÂ¦ Â¦pri nc ip lesÂ¦ Â¦andÂ¦ Â¦v al uesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦  - Â¦w ideÂ¦ ğ‹‡Â¦ ru leÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦la wÂ¦ ğ‹‡ Â¦reportÂ¦ ,â– Â¦aÂ¦ Â¦newÂ¦ Â¦prev en tiveÂ¦ Â¦t oo lÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦h ear tÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦ ru leÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦la wÂ¦ ğ‹‡ Â¦me ch an is mÂ¦ .
ğ‹‡ Â¦ste ll aÂ¦ ğ‹‡ Â¦k y r ia k i desÂ¦  Â¦m ee tingÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦newÂ¦  Â¦riskÂ¦ Â¦as se ss mentÂ¦ Â¦ca llsÂ¦ Â¦forÂ¦ Â¦ stric terÂ¦ Â¦measuresÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦increasedÂ¦ Â¦infectionÂ¦ Â¦r atesÂ¦
ğ‹‡Â¦theÂ¦  Â¦hasÂ¦ Â¦itsÂ¦ Â¦up d atedÂ¦ Â¦rap idÂ¦ Â¦riskÂ¦ Â¦as se ss mentÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦e p ide mi ologicalÂ¦ Â¦s itu ationÂ¦ Â¦andÂ¦ Â¦f in dsÂ¦ Â¦thatÂ¦ Â¦infectionÂ¦ Â¦r atesÂ¦ Â¦haveÂ¦ Â¦increasedÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  Â¦andÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦anÂ¦ Â¦e mploy e eÂ¦ Â¦isÂ¦ Â¦cont ro llingÂ¦ Â¦aÂ¦ Â¦ma ch ineÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦fa ct oryÂ¦ 
Â¦2 2Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦w el c omesÂ¦ Â¦f in al is ationÂ¦ Â¦ofÂ¦ Â¦gu ar an te eÂ¦ Â¦systemÂ¦ Â¦forÂ¦ â– â‚¬ Â¦100Â¦ Â¦bi ll ionÂ¦  Â¦inst ru mentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦w el c omesÂ¦ Â¦theÂ¦ Â¦activ ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦  â–-â– Â¦theÂ¦ Â¦temp or aryÂ¦ ğ‹‡ Â¦supportÂ¦ Â¦m it ig atingÂ¦ ğ‹‡ Â¦u ne mploy mentÂ¦ ğ‹‡ Â¦r is ksÂ¦ Â¦inÂ¦ ğ‹‡ Â¦emergencyÂ¦ Â¦inst ru mentÂ¦ ,â– Â¦whichÂ¦ Â¦willÂ¦ Â¦provideÂ¦ Â¦upÂ¦ Â¦toÂ¦ â– â‚¬ Â¦100Â¦ Â¦bi ll ionÂ¦ Â¦inÂ¦ Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦protectÂ¦ Â¦workersÂ¦ Â¦andÂ¦ Â¦j ob sÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
ğ‹‡ Â¦ne xtÂ¦ ğ‹‡ Â¦gener ationÂ¦  
Â¦1 7Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entsÂ¦ Â¦ne xtÂ¦ Â¦ste psÂ¦ Â¦forÂ¦ â– â‚¬ Â¦6 7 2Â¦ . Â¦5Â¦ Â¦bi ll ionÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facil ityÂ¦ Â¦inÂ¦ Â¦2021Â¦ ğ‹‡ Â¦an n ualÂ¦ ğ‹‡Â¦s us ta in ableÂ¦ ğ‹‡ Â¦gr ow thÂ¦ ğ‹‡ Â¦stra te g yÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦s etÂ¦ Â¦outÂ¦ Â¦gu id anceÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦imp le me nt ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facil ityÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦2021Â¦ ğ‹‡ Â¦an n ualÂ¦ ğ‹‡Â¦s us ta in ableÂ¦ ğ‹‡ Â¦gr ow thÂ¦ ğ‹‡ Â¦stra te g yÂ¦ .
ğ‹‡ Â¦twoÂ¦ Â¦sc ien ti stsÂ¦ Â¦wor kingÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦l ab Â¦ 
Â¦10Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦worldÂ¦ ğ‹‡ Â¦healthÂ¦ ğ‹‡ Â¦or g an is ationÂ¦ Â¦toÂ¦ Â¦st re ng th enÂ¦ Â¦coronavirusÂ¦ Â¦tre at mentsÂ¦ Â¦inÂ¦ Â¦globalÂ¦ Â¦coll a bor ationÂ¦
ğ‹‡ Â¦to dayÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦pres identÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ ,â– ğ‹‡ Â¦u rs ul aÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦dir ectorÂ¦ ğ‹‡ Â¦generalÂ¦ Â¦ofÂ¦ Â¦theÂ¦  ,â– ğ‹‡Â¦t ed ro sÂ¦ ğ‹‡ Â¦ad h an omÂ¦ ğ‹‡ Â¦g he b re y es usÂ¦ ,â– Â¦la un chedÂ¦ Â¦andÂ¦ Â¦c oÂ¦ - Â¦h os tedÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦m ee tingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦highÂ¦ ğ‹‡ Â¦levelÂ¦ ğ‹‡ Â¦facil it ationÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦toÂ¦ Â¦sp e edÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦andÂ¦ Â¦dep lo y mentÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ ,â– Â¦testsÂ¦ Â¦andÂ¦ Â¦tre at mentsÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
Â¦vaccinesÂ¦ 
Â¦9Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦ad dsÂ¦ Â¦toÂ¦ Â¦vaccinesÂ¦ Â¦p ort f o li oÂ¦ Â¦followingÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦  - ğ‹‡Â¦p f iz erÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦co nc lu dedÂ¦ Â¦ex pl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦si x thÂ¦ Â¦m an u fa ct ur erÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦pote ntialÂ¦ Â¦p ur ch aseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ .
Â¦tra v el erÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦tra inÂ¦ Â¦st ationÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦se p te mberÂ¦ Â¦2020Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦h arm on iseÂ¦ Â¦nationalÂ¦ Â¦measuresÂ¦ Â¦aff ectingÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ Â¦prop os alÂ¦ Â¦forÂ¦ Â¦aÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ ğ‹‡ Â¦recomm end ationÂ¦ Â¦toÂ¦ Â¦imp ro veÂ¦ Â¦theÂ¦ Â¦co or d inationÂ¦ Â¦andÂ¦ Â¦comm un ic ationÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦thatÂ¦ Â¦restrictÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ .
Â¦2 7Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â–  Â¦chan n elsÂ¦ Â¦crit icalÂ¦ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡ Â¦ind iaÂ¦ Â¦v iaÂ¦  ğ‹‡Â¦c iv ilÂ¦ ğ‹‡ Â¦prote ctionÂ¦ ğ‹‡ Â¦me ch an is mÂ¦
ğ‹‡Â¦aÂ¦ Â¦sh ip mentÂ¦ Â¦ofÂ¦ Â¦ ur ge ntlyÂ¦ Â¦nee dedÂ¦ Â¦o x yg enÂ¦ ,â– Â¦medic ineÂ¦ Â¦andÂ¦ Â¦equipmentÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦del iv eredÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦c om ingÂ¦ Â¦daysÂ¦ Â¦byÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ ğ‹‡ Â¦ind iaÂ¦ ,â– Â¦followingÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ' Â¦sÂ¦ Â¦re qu estÂ¦ Â¦forÂ¦ Â¦supportÂ¦ .
ğ‹‡Â¦b er la y m on tÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– â‚¬ Â¦5 6 2Â¦ . Â¦5Â¦ Â¦millionÂ¦ Â¦inÂ¦  -  Â¦in ve st mentÂ¦ Â¦f un dingÂ¦ Â¦all oc atedÂ¦ Â¦toÂ¦ ğ‹‡Â¦b ul g ar iaÂ¦ ,â– ğ‹‡Â¦f in landÂ¦ ,â– ğ‹‡Â¦f r anceÂ¦ Â¦andÂ¦ ğ‹‡ Â¦li th u an iaÂ¦
 -  Â¦in ve st mentsÂ¦ Â¦ofÂ¦ Â¦aroundÂ¦ â– â‚¬ Â¦5 6 2Â¦ .
ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– Â¦100Â¦ Â¦millionÂ¦ Â¦vacc in ationsÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦inÂ¦ Â¦theÂ¦ 
ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ :â– â€œ ğ‹‡ Â¦vacc inationÂ¦ Â¦isÂ¦ Â¦p ic kingÂ¦ Â¦upÂ¦ Â¦sp e edÂ¦ Â¦acrossÂ¦ ğ‹‡Â¦e ur opeÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦haveÂ¦ Â¦receivedÂ¦ Â¦overÂ¦ Â¦1 2 6Â¦ Â¦millionÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦asÂ¦ Â¦ofÂ¦ Â¦y e st er dayÂ¦ .
ğ‹‡Â¦p i ct ureÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y m on tÂ¦ Â¦f ac a deÂ¦ 
Â¦14Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦g etsÂ¦ Â¦rea dyÂ¦ Â¦toÂ¦ Â¦ra iseÂ¦ Â¦upÂ¦ Â¦toÂ¦ â– â‚¬ Â¦8 00Â¦ Â¦bi ll ionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦f un dÂ¦ Â¦theÂ¦ Â¦reco ve ryÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦ta k enÂ¦ Â¦ste psÂ¦ Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦thatÂ¦ Â¦ bor r owingÂ¦ Â¦underÂ¦ Â¦theÂ¦ Â¦temp or aryÂ¦ Â¦reco ve ryÂ¦ Â¦inst ru mentÂ¦  Â¦willÂ¦ Â¦beÂ¦ Â¦fi na nc edÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦ad v an ta ge o usÂ¦ Â¦ter msÂ¦ Â¦forÂ¦  Â¦countriesÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦c itiz ensÂ¦ .
ğ‹‡Â¦h um an i ta ri anÂ¦ Â¦a idÂ¦ Â¦workersÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦w a re ho useÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦teamÂ¦ ğ‹‡Â¦e ur opeÂ¦ Â¦contin uesÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦part n erÂ¦ Â¦countriesÂ¦ Â¦withÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ â– â‚¬ Â¦26Â¦ Â¦bi ll ionÂ¦ Â¦dis b ur sedÂ¦ Â¦inÂ¦ Â¦oneÂ¦ Â¦yearÂ¦
ğ‹‡Â¦byÂ¦ Â¦1Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ ,â– ğ‹‡ Â¦teamÂ¦ ğ‹‡Â¦e ur opeÂ¦ Â¦hadÂ¦ Â¦al rea dyÂ¦ Â¦supp or tedÂ¦ Â¦overÂ¦ Â¦1 3 0Â¦ Â¦part n erÂ¦ Â¦countriesÂ¦ Â¦aroundÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦withÂ¦ Â¦overÂ¦ â– â‚¬ Â¦26Â¦ Â¦bi ll ionÂ¦ 
Â¦7Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦healthÂ¦ ğ‹‡Â¦s um mi tÂ¦ :â– ğ‹‡Â¦stayÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦v iaÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦we b s iteÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦publ ishedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦we b s iteÂ¦ Â¦withÂ¦ Â¦k e yÂ¦ Â¦informationÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦up c om ingÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡ Â¦healthÂ¦ ğ‹‡Â¦s um mi tÂ¦ .
ğ‹‡Â¦ im ageÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y m on tÂ¦ Â¦b an n erÂ¦ â–" ğ‹‡ Â¦ne xtÂ¦ ğ‹‡ Â¦gener ationÂ¦  
Â¦6Â¦ ğ‹‡ Â¦aprilÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦firstÂ¦  -  Â¦supportÂ¦ Â¦measuresÂ¦ Â¦forÂ¦ Â¦reco ve ryÂ¦ Â¦andÂ¦ Â¦trans itionÂ¦ Â¦appr ovedÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡ Â¦ne ther l an dsÂ¦ Â¦andÂ¦ ğ‹‡ Â¦a u str iaÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦appr ovedÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦dec i si onsÂ¦ Â¦underÂ¦  -  Â¦invol vingÂ¦ Â¦mod if icationsÂ¦ Â¦ofÂ¦ Â¦fourÂ¦ Â¦op e ra tionalÂ¦ Â¦pr ogra mm esÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦regi on alÂ¦ ğ‹‡ Â¦developmentÂ¦ ğ‹‡Â¦f un dÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦ne ther l an dsÂ¦ Â¦andÂ¦ ğ‹‡ Â¦a u str iaÂ¦ Â¦thatÂ¦ Â¦willÂ¦ Â¦increaseÂ¦ Â¦theÂ¦ Â¦f un dingÂ¦ Â¦availableÂ¦ Â¦forÂ¦ Â¦in ve st mentsÂ¦ Â¦byÂ¦ Â¦ne arlyÂ¦ â– â‚¬ Â¦2 6 2Â¦ Â¦millionÂ¦ Â¦fromÂ¦  -  .
Â¦work erÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦sho pÂ¦ 
Â¦30Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sesÂ¦ Â¦furtherÂ¦ â– â‚¬ Â¦13Â¦ Â¦bi ll ionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦6Â¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦workersÂ¦ Â¦andÂ¦ Â¦j ob sÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦dis b ur sedÂ¦ â– â‚¬ Â¦13Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ Â¦si xÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦si x thÂ¦ Â¦inst al mentÂ¦ Â¦ofÂ¦ Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦underÂ¦ Â¦theÂ¦  Â¦inst ru mentÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦j ob sÂ¦ Â¦andÂ¦ Â¦workersÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦n ur seÂ¦
Â¦26Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– â‚¬ Â¦5Â¦ . Â¦1Â¦ Â¦bi ll ionÂ¦  Â¦ent ersÂ¦ Â¦intoÂ¦ Â¦for ceÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦w el c o medÂ¦ Â¦theÂ¦  Â¦pr ogra m meÂ¦ Â¦ent eringÂ¦ Â¦intoÂ¦ Â¦for ceÂ¦ .
ğ‹‡Â¦l otÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦dosesÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–-â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦st re ng th ensÂ¦ Â¦trans pa re ncyÂ¦ Â¦andÂ¦ Â¦author is ationÂ¦ Â¦me ch an is mÂ¦ Â¦forÂ¦ Â¦exp ortsÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦int ro duc edÂ¦ Â¦ad di tionalÂ¦ Â¦pri nc ip lesÂ¦ Â¦forÂ¦ Â¦consid er ationÂ¦ Â¦beforeÂ¦ Â¦author isingÂ¦ Â¦exp ortsÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ :â– Â¦rec ip r oc ityÂ¦ Â¦andÂ¦ Â¦prop or tion alityÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦m anÂ¦ Â¦su p erv isingÂ¦ Â¦aÂ¦ Â¦y ou ngÂ¦ Â¦e mploy erÂ¦ 
Â¦2 2Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦reportÂ¦ Â¦conf ir msÂ¦  ' Â¦sÂ¦ Â¦s uc c essÂ¦ Â¦inÂ¦ Â¦prot ectingÂ¦ Â¦j ob sÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦publ ishedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦pre li min aryÂ¦ Â¦as se ss mentÂ¦ Â¦ofÂ¦  ,â– Â¦theÂ¦ â– â‚¬ Â¦100Â¦ Â¦bi ll ionÂ¦ Â¦inst ru mentÂ¦ Â¦d ed ic atedÂ¦ Â¦toÂ¦ Â¦prot ectingÂ¦ Â¦j ob sÂ¦ Â¦andÂ¦ Â¦ec on om iesÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦eff ectsÂ¦ Â¦ofÂ¦ Â¦theÂ¦  - Â¦19Â¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦g ir lÂ¦ Â¦wai tingÂ¦ Â¦inÂ¦ Â¦ lineÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦air p ortÂ¦ 
Â¦1 7Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦aÂ¦ ğ‹‡Â¦d ig it alÂ¦ ğ‹‡ Â¦g re enÂ¦ ğ‹‡ Â¦ce rt ific ateÂ¦ Â¦withÂ¦ Â¦informationÂ¦ Â¦aboutÂ¦ Â¦vacc inationÂ¦ ,â– Â¦testsÂ¦ Â¦andÂ¦ Â¦reco ve ryÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦ es ta bl ishÂ¦ Â¦anÂ¦  - Â¦w ideÂ¦ Â¦fra me w or kÂ¦ Â¦onÂ¦ Â¦aÂ¦ ğ‹‡Â¦d ig it alÂ¦ ğ‹‡ Â¦g re enÂ¦ ğ‹‡ Â¦ce rt ific ateÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦i ss u anceÂ¦ ,â– Â¦ ver ific ationÂ¦ Â¦andÂ¦ Â¦ac ce pt anceÂ¦ Â¦ofÂ¦ Â¦vacc inationÂ¦ ,â– Â¦testingÂ¦ Â¦andÂ¦ Â¦reco ve ryÂ¦ Â¦ce rt ific atesÂ¦ .
ğ‹‡ Â¦twoÂ¦ Â¦peopleÂ¦ Â¦t al kingÂ¦ 
Â¦16Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–-â– ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sesÂ¦ Â¦furtherÂ¦ â– â‚¬ Â¦9Â¦ Â¦bi ll ionÂ¦ Â¦underÂ¦  Â¦toÂ¦ Â¦7Â¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦dis b ur sedÂ¦ â– â‚¬ Â¦9Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ Â¦7Â¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦f if thÂ¦ Â¦inst al mentÂ¦ Â¦underÂ¦ Â¦theÂ¦  Â¦inst ru mentÂ¦ .
Â¦vaccineÂ¦ Â¦ vi alsÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦author i sesÂ¦ Â¦fo ur thÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mark e tingÂ¦ Â¦author is ationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦jo h ns onÂ¦ â– & â– ğ‹‡ Â¦jo h ns onÂ¦ ,â– Â¦ma kingÂ¦ Â¦itÂ¦ Â¦theÂ¦ Â¦fo ur thÂ¦ Â¦vaccineÂ¦ Â¦author i sedÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
ğ‹‡Â¦aÂ¦ Â¦n ur seÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦useÂ¦ â– â‚¬ Â¦5 3 0Â¦ Â¦millionÂ¦ Â¦underÂ¦ Â¦theÂ¦  ğ‹‡Â¦s ol id ar ityÂ¦ Â¦f un dÂ¦ Â¦toÂ¦ Â¦f ightÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦p ut tingÂ¦ Â¦for w ardÂ¦ Â¦aÂ¦ Â¦p ac k ageÂ¦ Â¦ofÂ¦ Â¦al m ostÂ¦ â– â‚¬ Â¦5 3 0Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦fi na nc ialÂ¦ Â¦supportÂ¦ Â¦underÂ¦ Â¦theÂ¦  ğ‹‡Â¦s ol id ar ityÂ¦ ğ‹‡Â¦f un dÂ¦ Â¦toÂ¦ Â¦supportÂ¦ Â¦publicÂ¦ Â¦exp end it ureÂ¦ Â¦onÂ¦ Â¦medicalÂ¦ Â¦andÂ¦ Â¦personalÂ¦ Â¦prot ectiveÂ¦ Â¦equipmentÂ¦ ,â– Â¦emergencyÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦populationÂ¦ ,â– Â¦andÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦preventÂ¦ ,â– Â¦monit orÂ¦ Â¦andÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦c arg oÂ¦ Â¦fre ightÂ¦ Â¦onÂ¦ Â¦p al et tesÂ¦ Â¦b ra ndedÂ¦ Â¦withÂ¦  Â¦f la gÂ¦ Â¦beingÂ¦ Â¦lo a dedÂ¦ Â¦o nt oÂ¦ Â¦anÂ¦ Â¦air pl an eÂ¦ 
Â¦10Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦newÂ¦ Â¦a ctionÂ¦ Â¦forÂ¦  ' Â¦sÂ¦ Â¦globalÂ¦ Â¦a idÂ¦ Â¦de li ve ryÂ¦ Â¦cha ll en gedÂ¦ Â¦byÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ Â¦onÂ¦ Â¦h um an i ta ri anÂ¦ Â¦a ctionÂ¦ ,â– Â¦s ettingÂ¦ Â¦outÂ¦ Â¦howÂ¦ Â¦theÂ¦  Â¦canÂ¦ Â¦ste pÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦me etÂ¦ Â¦h um an i ta ri anÂ¦ Â¦cha ll en gesÂ¦ Â¦br ou gh tÂ¦ Â¦onÂ¦ Â¦byÂ¦ Â¦theÂ¦  - Â¦19Â¦ Â¦pandemicÂ¦ 
Â¦4Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦e ns ur ingÂ¦ Â¦aÂ¦ Â¦j ob Â¦ - Â¦ ri chÂ¦ Â¦reco ve ryÂ¦ :â– ğ‹‡ Â¦a ctionÂ¦ Â¦pl anÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦socialÂ¦ ğ‹‡Â¦ ri gh tsÂ¦ Â¦s etsÂ¦ Â¦outÂ¦ Â¦effectiveÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦e mploy mentÂ¦
ğ‹‡Â¦asÂ¦ Â¦par tÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦a ctionÂ¦ ğ‹‡ Â¦pl anÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦p il la rÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦socialÂ¦ ğ‹‡Â¦ ri gh tsÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦pres entedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦recomm end ationÂ¦ Â¦forÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦e aseÂ¦ Â¦theÂ¦ Â¦trans itionÂ¦ Â¦fromÂ¦ Â¦c ri sisÂ¦ - Â¦j ob Â¦ - Â¦supportÂ¦ Â¦toÂ¦ Â¦cre atingÂ¦ Â¦f ut ureÂ¦ - Â¦pr oo fÂ¦ Â¦j ob sÂ¦ :â– ğ‹‡ Â¦effectiveÂ¦ ğ‹‡ Â¦ac tiveÂ¦ ğ‹‡ Â¦supportÂ¦ Â¦toÂ¦ ğ‹‡Â¦e mploy mentÂ¦ â–(  
Â¦3Â¦ ğ‹‡ Â¦marchÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦oneÂ¦ Â¦yearÂ¦ Â¦sinceÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦  - Â¦19Â¦ :â– Â¦up d atedÂ¦ Â¦f is c alÂ¦ Â¦pol ic yÂ¦ Â¦responseÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ Â¦provid ingÂ¦ ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦withÂ¦ Â¦b ro adÂ¦ Â¦gu id anceÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦con duc tÂ¦ Â¦ofÂ¦ Â¦f is c alÂ¦ Â¦pol ic yÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦periodÂ¦ Â¦a h eadÂ¦ Â¦andÂ¦ Â¦s ettingÂ¦ Â¦outÂ¦ Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ ' Â¦sÂ¦ Â¦consid er ationsÂ¦ Â¦reg ar dingÂ¦ Â¦theÂ¦ Â¦d ea ct iv ationÂ¦ Â¦orÂ¦ Â¦contin u edÂ¦ Â¦activ ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦ esc ap eÂ¦ Â¦c la useÂ¦ .
ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ 
Â¦24Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦sp o keÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c itiz enÂ¦ ğ‹‡ Â¦ca m pa ignÂ¦ Â¦la un chÂ¦ Â¦ev entÂ¦ â– â€˜ ğ‹‡Â¦aÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ ğ‹‡ Â¦pl anÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡ Â¦worldÂ¦ '
ğ‹‡ Â¦atÂ¦ Â¦theÂ¦ Â¦la un chÂ¦ Â¦evenÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦globalÂ¦ ğ‹‡Â¦c itiz enÂ¦ ğ‹‡ Â¦ca m pa ignÂ¦ ,â– ğ‹‡ Â¦pres identÂ¦ Â¦v onÂ¦ Â¦ derÂ¦ ğ‹‡ Â¦le y enÂ¦ Â¦saidÂ¦ :â– ğ‹‡Â¦l etÂ¦ Â¦usÂ¦ Â¦over c omeÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦globalÂ¦ Â¦vacc inationÂ¦ Â¦ca m pa ignÂ¦ .
Â¦19Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–-â–  Â¦do ub lesÂ¦ Â¦cont rib utionÂ¦ Â¦toÂ¦  Â¦toÂ¦ â– â‚¬ Â¦1Â¦ Â¦bi ll ionÂ¦ Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccinesÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦un ionÂ¦ Â¦announcedÂ¦ Â¦anÂ¦ Â¦ad di tionalÂ¦ â– â‚¬ Â¦5 00Â¦ Â¦millionÂ¦ Â¦forÂ¦ Â¦theÂ¦  ğ‹‡ Â¦facil ityÂ¦ ,â– Â¦d ou bl ingÂ¦ Â¦itsÂ¦ Â¦cont rib utionÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦in i ti ativeÂ¦ Â¦sec ureÂ¦ Â¦f ai rÂ¦ Â¦andÂ¦ Â¦e qu it ableÂ¦ Â¦acc essÂ¦ Â¦toÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦  - Â¦19Â¦ Â¦vaccinesÂ¦ .
Â¦1 7Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦t ac k lesÂ¦  - Â¦19Â¦ Â¦vari a ntsÂ¦ Â¦whileÂ¦ Â¦incre as ingÂ¦ Â¦pre par ed nessÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦willÂ¦ Â¦ es ta bl ishÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦bi oÂ¦ - Â¦def enceÂ¦ Â¦pl anÂ¦ Â¦calledÂ¦  ğ‹‡ Â¦inc ub at orÂ¦ Â¦toÂ¦ Â¦t ac k leÂ¦ Â¦sh ortÂ¦ Â¦toÂ¦ Â¦me di umÂ¦ - Â¦ter mÂ¦ Â¦th rea tsÂ¦ Â¦andÂ¦ Â¦s im ul ta ne o us lyÂ¦ Â¦pre p areÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦f ut ureÂ¦ Â¦byÂ¦ Â¦ser vingÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦b lu e p r in tÂ¦ Â¦forÂ¦ Â¦theÂ¦  â€™ Â¦sÂ¦ Â¦longÂ¦ Â¦ter mÂ¦ Â¦pre par ed nessÂ¦ Â¦forÂ¦ Â¦healthÂ¦ Â¦e mer ge nc iesÂ¦ 
Â¦11Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦w in terÂ¦ Â¦2021Â¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦ Â¦publ ishedÂ¦ :â– Â¦aÂ¦ Â¦cha ll en gingÂ¦ Â¦w in terÂ¦ ,â– Â¦butÂ¦ Â¦l ightÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦t un ne lÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦publ ishedÂ¦ Â¦itsÂ¦ ğ‹‡Â¦w in terÂ¦ Â¦2021Â¦ ğ‹‡ Â¦ec onomicÂ¦ ğ‹‡ Â¦for ec astÂ¦ ,â– Â¦whichÂ¦ Â¦pro j ectsÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦e ur oÂ¦ Â¦a reaÂ¦ Â¦ec on om yÂ¦ Â¦willÂ¦ Â¦gr owÂ¦ Â¦byÂ¦ Â¦3Â¦ .
ğ‹‡Â¦ im ageÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦b er la y m on tÂ¦ Â¦b an n erÂ¦ â–" ğ‹‡ Â¦ne xtÂ¦ ğ‹‡ Â¦gener ationÂ¦  
Â¦10Â¦ ğ‹‡ Â¦februaryÂ¦ Â¦2021Â¦ â–â€“â– â‚¬ Â¦6 7 2Â¦ . Â¦5Â¦ Â¦bi ll ionÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facil ityÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦me mberÂ¦ Â¦statesÂ¦ Â¦e mer geÂ¦ Â¦st ro ngerÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦c ri sisÂ¦ Â¦appr ovedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦w el c omesÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦par l ia mentÂ¦ ' Â¦sÂ¦ Â¦v ot eÂ¦ Â¦conf ir m ingÂ¦ Â¦theÂ¦ Â¦pol it icalÂ¦ Â¦ag r ee mentÂ¦ Â¦rea chedÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦reco ve ryÂ¦ Â¦andÂ¦ ğ‹‡ Â¦re si li enceÂ¦ ğ‹‡ Â¦facil ityÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦decemberÂ¦ Â¦2020Â¦ .
ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦ 
Â¦2 9Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦author i sesÂ¦ Â¦thir dÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mark e tingÂ¦ Â¦author is ationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦a st ra ğ‹‡ z enecaÂ¦ ,â– Â¦ma kingÂ¦ Â¦itÂ¦ Â¦theÂ¦ Â¦thir dÂ¦ Â¦vaccineÂ¦ Â¦author i sedÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
Â¦pr oo fÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vacc inationÂ¦ 
Â¦2 7Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â–  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦ad op tÂ¦ Â¦gu id el inesÂ¦ Â¦onÂ¦ Â¦pr oo fÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vacc inationÂ¦ Â¦forÂ¦ Â¦medicalÂ¦ Â¦p ur p o sesÂ¦
ğ‹‡Â¦theÂ¦  ğ‹‡ Â¦me mbersÂ¦ ğ‹‡ Â¦statesÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦supportÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ ,â– Â¦ad op tedÂ¦ Â¦gu id el inesÂ¦ Â¦onÂ¦ Â¦pr oo fÂ¦ Â¦ofÂ¦  - Â¦19Â¦ Â¦vacc inationÂ¦ Â¦forÂ¦ Â¦medicalÂ¦ Â¦p ur p o sesÂ¦ .
ğ‹‡ Â¦peopleÂ¦ Â¦w al kingÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦air p ortÂ¦ 
Â¦2 5Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦up d ateÂ¦ Â¦theÂ¦ Â¦co or d in atedÂ¦ Â¦appro a chÂ¦ Â¦onÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦in sideÂ¦ Â¦theÂ¦  ,â– Â¦andÂ¦ Â¦travelÂ¦ Â¦fromÂ¦ Â¦thir dÂ¦ Â¦countriesÂ¦ Â¦toÂ¦ Â¦theÂ¦ 
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦isÂ¦ Â¦prop os ingÂ¦ Â¦ad di tionalÂ¦ Â¦sa f e g u ardsÂ¦ Â¦andÂ¦ Â¦requir e mentsÂ¦ Â¦forÂ¦ Â¦internationalÂ¦ Â¦tra ve ll ersÂ¦ Â¦intoÂ¦ Â¦theÂ¦  ,â– Â¦andÂ¦ Â¦toÂ¦ Â¦up d ateÂ¦ Â¦theÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ ğ‹‡ Â¦recomm end ationÂ¦ Â¦onÂ¦ Â¦co or d in atedÂ¦ Â¦measuresÂ¦ Â¦aff ectingÂ¦ Â¦fre eÂ¦ Â¦mo ve mentÂ¦ Â¦withinÂ¦ Â¦theÂ¦  .
Â¦vaccinesÂ¦ 
Â¦ 21Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–-â–  Â¦lea d ersÂ¦ Â¦ag re edÂ¦ Â¦onÂ¦ Â¦sp ee dingÂ¦ Â¦upÂ¦ Â¦vacc inationÂ¦ Â¦andÂ¦ Â¦disc us sedÂ¦ Â¦otherÂ¦ Â¦measuresÂ¦ Â¦atÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦cou nc ilÂ¦
ğ‹‡ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦cou nc ilÂ¦ Â¦m ee tingÂ¦ ,â– Â¦lea d ersÂ¦ Â¦no tedÂ¦ Â¦theÂ¦ Â¦s eri o us nessÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦s itu ationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦l ightÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦vari a ntsÂ¦ .
Â¦personÂ¦ Â¦beingÂ¦ Â¦vaccinatedÂ¦ 
Â¦19Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦s etsÂ¦ Â¦outÂ¦ Â¦k e yÂ¦ Â¦ac tionsÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦unitedÂ¦ Â¦f r on tÂ¦ Â¦toÂ¦ Â¦be atÂ¦  - Â¦19Â¦
ğ‹‡ Â¦twoÂ¦ Â¦daysÂ¦ Â¦a h eadÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦lea d ersÂ¦ â€™ â– Â¦v ide oc on f er enceÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦co or d in ateÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦s etÂ¦ Â¦outÂ¦ Â¦ac tionsÂ¦ Â¦inÂ¦ Â¦aÂ¦ ğ‹‡ Â¦comm un ic ationÂ¦ Â¦toÂ¦ Â¦ste pÂ¦ Â¦upÂ¦ Â¦theÂ¦ Â¦f ightÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦andÂ¦ Â¦sp e edÂ¦ Â¦upÂ¦ Â¦vacc inationÂ¦ .
Â¦g ir lÂ¦ Â¦gettingÂ¦ Â¦vaccinatedÂ¦ 
Â¦12Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–â€“â– ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦co nc lu desÂ¦ Â¦ex pl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ ğ‹‡ Â¦v al ne v aÂ¦ Â¦toÂ¦ Â¦sec ureÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦pote ntialÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦co nc lu dedÂ¦ Â¦ex pl or atoryÂ¦ Â¦t al ksÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an yÂ¦ ğ‹‡ Â¦v al ne v aÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦v ie wÂ¦ Â¦toÂ¦ Â¦p ur ch as ingÂ¦ Â¦itsÂ¦ Â¦pote ntialÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦o nceÂ¦ Â¦pr ov enÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ .
Â¦p f iz erÂ¦ Â¦vaccineÂ¦ 
Â¦8Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop o sesÂ¦ Â¦toÂ¦ Â¦p ur ch aseÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦3 00Â¦ Â¦millionÂ¦ Â¦ad di tionalÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦  - ğ‹‡Â¦p f iz erÂ¦ Â¦vaccineÂ¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦prop osedÂ¦ Â¦toÂ¦  ğ‹‡ Â¦me mberÂ¦ ğ‹‡ Â¦statesÂ¦ Â¦toÂ¦ Â¦p ur ch aseÂ¦ Â¦anÂ¦ Â¦ad di tionalÂ¦ Â¦2 00Â¦ Â¦millionÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦theÂ¦  Â¦andÂ¦ ğ‹‡Â¦p f iz erÂ¦  - Â¦19Â¦ Â¦vaccineÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦o ptionÂ¦ Â¦ofÂ¦ Â¦ac qu ir ingÂ¦ Â¦anotherÂ¦ Â¦100Â¦ Â¦millionÂ¦ Â¦dosesÂ¦ .
Â¦vacc inationÂ¦ Â¦medicalÂ¦ Â¦st ud entÂ¦ 
Â¦6Â¦ ğ‹‡ Â¦januaryÂ¦ Â¦2021Â¦ â–-â– ğ‹‡ Â¦europeanÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦author i sesÂ¦ Â¦secondÂ¦ Â¦safeÂ¦ Â¦andÂ¦ Â¦effectiveÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦c om mi ssionÂ¦ Â¦hasÂ¦ Â¦gr an tedÂ¦ Â¦aÂ¦ Â¦con di tionalÂ¦ Â¦mark e tingÂ¦ Â¦author is ationÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦  - Â¦19Â¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦mod er naÂ¦ ,â– Â¦theÂ¦ Â¦secondÂ¦ Â¦vaccineÂ¦ Â¦author i sedÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦vacc inationÂ¦ Â¦prot ectsÂ¦ Â¦peopleÂ¦ Â¦againstÂ¦ Â¦ser iousÂ¦ Â¦andÂ¦ Â¦l ifeÂ¦ - Â¦th re at eningÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦influenzaÂ¦ â–( Â¦fluÂ¦ ),â– Â¦di ph ther iaÂ¦ ,â– Â¦t et an usÂ¦ ,â– Â¦per t us sisÂ¦ â–( Â¦w ho op ingÂ¦ Â¦coughÂ¦ ),â– Â¦me as lesÂ¦ ,â– Â¦m um psÂ¦ ,â– Â¦r ub e ll aÂ¦ â–( ğ‹‡ Â¦g erm anÂ¦ Â¦me as lesÂ¦ ),â– Â¦m en i ng oc oc c alÂ¦ Â¦diseaseÂ¦ ,â– Â¦inv as iveÂ¦ Â¦p ne um oc oc c alÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦po li oÂ¦ .
ğ‹‡ Â¦eachÂ¦ Â¦yearÂ¦ ,â– Â¦vacc inationÂ¦ Â¦sto psÂ¦ Â¦2Â¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦p astÂ¦ ,â– Â¦manyÂ¦ Â¦peopleÂ¦ Â¦d iedÂ¦ Â¦ofÂ¦ Â¦diseasesÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦n owÂ¦ Â¦beÂ¦ Â¦prev entedÂ¦ Â¦throughÂ¦ Â¦vacc inationÂ¦ .
ğ‹‡ Â¦me as lesÂ¦
Â¦12Â¦ - Â¦18Â¦ Â¦peopleÂ¦ â–
ğ‹‡Â¦theÂ¦ Â¦centreÂ¦ Â¦d otÂ¦ Â¦rep r es entÂ¦ Â¦oneÂ¦ Â¦personÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦h el psÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦diseaseÂ¦ Â¦inÂ¦ Â¦comm un itiesÂ¦ .
ğ‹‡ Â¦th an ksÂ¦ Â¦toÂ¦ Â¦vacc inationÂ¦ :
Â¦s ma ll p o xÂ¦ Â¦isÂ¦ Â¦n owÂ¦ Â¦e rad ic atedÂ¦ Â¦worldwideÂ¦ ;
Â¦transmissionÂ¦ Â¦ofÂ¦ Â¦po li oÂ¦ Â¦hasÂ¦ Â¦e ndedÂ¦ Â¦inÂ¦ Â¦mostÂ¦ Â¦par tsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦e ur opeÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦alsoÂ¦ Â¦prev entsÂ¦ Â¦theÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦c er tainÂ¦ Â¦typ esÂ¦ Â¦ofÂ¦ Â¦pr eÂ¦ - Â¦cance ro usÂ¦ Â¦gr ow thsÂ¦ Â¦andÂ¦ Â¦ca nc ersÂ¦ ,â– Â¦forÂ¦ Â¦exampleÂ¦ :
Â¦vacc in atingÂ¦ Â¦againstÂ¦ Â¦h um an p ap i ll om aÂ¦ Â¦virusÂ¦ â–(  )â– Â¦canÂ¦ Â¦helpÂ¦ Â¦preventÂ¦ Â¦c erv icalÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦ca nc ersÂ¦ Â¦causedÂ¦ Â¦byÂ¦  Â¦infectionÂ¦ ;
Â¦vacc in atingÂ¦ Â¦againstÂ¦ Â¦he p at itisÂ¦ ğ‹‡Â¦b Â¦ Â¦canÂ¦ Â¦helpÂ¦ Â¦preventÂ¦ Â¦li verÂ¦ Â¦cance rÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦longÂ¦ - Â¦ter mÂ¦ Â¦he p at itisÂ¦ ğ‹‡Â¦b Â¦ Â¦infectionÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦pr ogra mm esÂ¦ Â¦haveÂ¦ Â¦wid erÂ¦ Â¦s oc i et alÂ¦ Â¦be ne f i tsÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦isÂ¦ Â¦theÂ¦ Â¦b estÂ¦ Â¦wayÂ¦ Â¦toÂ¦ Â¦ac qu ir eÂ¦ Â¦immun ityÂ¦ Â¦againstÂ¦ Â¦vaccineÂ¦ - Â¦pre vent ableÂ¦ Â¦diseasesÂ¦ ,â– Â¦asÂ¦ Â¦o pp osedÂ¦ Â¦toÂ¦ Â¦immun ityÂ¦ Â¦att a inedÂ¦ Â¦byÂ¦ Â¦gettingÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦prot ectsÂ¦ Â¦theÂ¦ Â¦vaccinatedÂ¦ Â¦pers onsÂ¦ Â¦andÂ¦ Â¦thoseÂ¦ Â¦aroundÂ¦ Â¦themÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦v ul n er ableÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦diseasesÂ¦ ,â– Â¦reduc ingÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦diseasesÂ¦ Â¦sprea dingÂ¦ Â¦amongÂ¦ Â¦familyÂ¦ Â¦me mbersÂ¦ ,â– Â¦schoolÂ¦ Â¦m atesÂ¦ Â¦orÂ¦ Â¦coll ea g uesÂ¦ ,â– Â¦f ri endsÂ¦ ,â– Â¦ne i gh bo ur sÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦peopleÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦communityÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦en oughÂ¦ Â¦peopleÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦populationÂ¦ Â¦areÂ¦ Â¦immuneÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦isÂ¦ Â¦thenÂ¦ Â¦un li k elyÂ¦ Â¦toÂ¦ Â¦spreadÂ¦ Â¦fromÂ¦ Â¦personÂ¦ Â¦toÂ¦ Â¦personÂ¦ .
ğ‹‡ Â¦communityÂ¦ Â¦immun ityÂ¦
ğ‹‡ Â¦communityÂ¦ Â¦immun ityÂ¦ Â¦occur sÂ¦ Â¦whenÂ¦ Â¦en oughÂ¦ Â¦peopleÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦populationÂ¦ Â¦areÂ¦ Â¦immuneÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦wayÂ¦ ,â– Â¦vaccinesÂ¦ Â¦ind ir ect lyÂ¦ Â¦protectÂ¦ Â¦othersÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦v ul n er ableÂ¦ Â¦toÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦me ansÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦cannotÂ¦ Â¦beÂ¦ Â¦vaccinatedÂ¦ ,â– Â¦forÂ¦ Â¦inst anceÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦to oÂ¦ Â¦y ou ngÂ¦ Â¦orÂ¦ Â¦all er g icÂ¦ Â¦toÂ¦ Â¦vaccineÂ¦ Â¦comp on entsÂ¦ ,â– Â¦be ne f i tÂ¦ Â¦fromÂ¦ Â¦othersÂ¦ Â¦beingÂ¦ Â¦vaccinatedÂ¦ ,â– Â¦becauseÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦cannotÂ¦ Â¦ ea si lyÂ¦ Â¦spreadÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦communityÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– Â¦toÂ¦ Â¦e ns ureÂ¦ Â¦communityÂ¦ Â¦immun ityÂ¦ Â¦againstÂ¦ Â¦me as lesÂ¦ ,â– Â¦publicÂ¦ Â¦healthÂ¦ Â¦author itiesÂ¦ Â¦recomm endÂ¦ Â¦thatÂ¦ Â¦9 5Â¦ %â– Â¦ofÂ¦ Â¦theÂ¦ Â¦populationÂ¦ Â¦areÂ¦ Â¦vaccinatedÂ¦ Â¦withÂ¦ Â¦twoÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦againstÂ¦ Â¦me as lesÂ¦ â–( Â¦theÂ¦  Â¦vaccineÂ¦ ,â– Â¦whichÂ¦ Â¦prot ectsÂ¦ Â¦againstÂ¦ Â¦me as lesÂ¦ ,â– Â¦m um psÂ¦ Â¦andÂ¦ Â¦r ub e ll aÂ¦ ).
ğ‹‡Â¦howeverÂ¦ ,â– Â¦peopleÂ¦ Â¦cannotÂ¦ Â¦r elyÂ¦ Â¦onÂ¦ Â¦communityÂ¦ Â¦immun ityÂ¦ Â¦forÂ¦ Â¦someÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦f ur th erm oreÂ¦ ,â– Â¦immun is ationÂ¦ Â¦pr ogra mm esÂ¦ Â¦helpÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦socialÂ¦ ,â– Â¦p s y ch ologicalÂ¦ Â¦andÂ¦ Â¦fi na nc ialÂ¦ Â¦b ur d ensÂ¦ Â¦ofÂ¦ Â¦diseaseÂ¦ Â¦onÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦gover n mentsÂ¦ ,â– Â¦reduc ingÂ¦ Â¦pre ss uresÂ¦ Â¦onÂ¦ Â¦healthcareÂ¦ Â¦andÂ¦ Â¦socialÂ¦ Â¦careÂ¦ Â¦sys temsÂ¦ Â¦andÂ¦ Â¦e na bl ingÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦p u rs ueÂ¦ Â¦produc tiveÂ¦ Â¦activ itiesÂ¦ Â¦includingÂ¦ Â¦educationÂ¦ Â¦andÂ¦ Â¦e mploy mentÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦prot ectsÂ¦ Â¦individualsÂ¦ Â¦againstÂ¦ Â¦diseasesÂ¦ Â¦thatÂ¦ Â¦couldÂ¦ Â¦haveÂ¦ Â¦ser iousÂ¦ Â¦con se qu en cesÂ¦ Â¦forÂ¦ Â¦theirÂ¦ Â¦healthÂ¦ ,â– Â¦forÂ¦ Â¦exampleÂ¦ :
Â¦di ph ther iaÂ¦ Â¦ki llsÂ¦ Â¦1Â¦ Â¦inÂ¦ Â¦everyÂ¦ Â¦10Â¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦getÂ¦ Â¦itÂ¦ ,â– Â¦evenÂ¦ Â¦withÂ¦ Â¦treatmentÂ¦ â–( Â¦1Â¦ ) ;
Â¦al m ostÂ¦ Â¦9Â¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦bab iesÂ¦ Â¦ bor nÂ¦ Â¦toÂ¦ Â¦mo th ersÂ¦ Â¦whoÂ¦ Â¦hadÂ¦ Â¦r ub e ll aÂ¦ Â¦inÂ¦ Â¦earlyÂ¦ Â¦pregn a ncyÂ¦ ,â– Â¦willÂ¦ Â¦su ff erÂ¦ Â¦fromÂ¦ Â¦co ng en it alÂ¦ Â¦r ub e ll aÂ¦ Â¦syndromeÂ¦ â–( Â¦withÂ¦ Â¦conditionsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦d ea f nessÂ¦ ,â– Â¦c at ar ac tsÂ¦ Â¦andÂ¦ Â¦learningÂ¦ Â¦dis ab il itiesÂ¦ ) â–( Â¦2Â¦ ) ;
Â¦m en i ng oc oc c alÂ¦ Â¦diseaseÂ¦ Â¦ki llsÂ¦ Â¦1Â¦ Â¦inÂ¦ Â¦10Â¦ Â¦peopleÂ¦ Â¦affectedÂ¦ ,â– Â¦evenÂ¦ Â¦withÂ¦ Â¦pro mp tÂ¦ Â¦diagn o sisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ ,â– Â¦whileÂ¦ Â¦prob le msÂ¦ Â¦includingÂ¦ Â¦ne ur ologicalÂ¦ Â¦orÂ¦ Â¦h earingÂ¦ Â¦imp a ir mentÂ¦ Â¦andÂ¦ Â¦a mp ut ationÂ¦ Â¦occur Â¦ Â¦inÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦20Â¦ %â– Â¦ofÂ¦ Â¦sur v iv orsÂ¦ â–( Â¦3Â¦ ) ;â–
Â¦me as lesÂ¦ Â¦isÂ¦ Â¦high lyÂ¦ Â¦conta g iousÂ¦ Â¦andÂ¦ Â¦3Â¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦peopleÂ¦ Â¦affectedÂ¦ Â¦develop Â¦ Â¦co mpl icationsÂ¦ â–( Â¦4Â¦ ),â– Â¦whichÂ¦ Â¦canÂ¦ Â¦includeÂ¦ Â¦ earÂ¦ Â¦infectionÂ¦ ,â– Â¦di arr ho e aÂ¦ ,â– Â¦pneumoniaÂ¦ Â¦andÂ¦ Â¦en ce ph al itisÂ¦ â–( Â¦inf la mm ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦b ra inÂ¦ Â¦ti ss ueÂ¦ ) ;
Â¦per t us sisÂ¦ â–( Â¦w ho op ingÂ¦ Â¦coughÂ¦ )â– Â¦canÂ¦ Â¦beÂ¦ Â¦partic ul arlyÂ¦ Â¦ser iousÂ¦ Â¦inÂ¦ Â¦in fa ntsÂ¦ ,â– Â¦ca us ingÂ¦ Â¦cou g hingÂ¦ Â¦sp e llsÂ¦ Â¦thatÂ¦ Â¦mayÂ¦ Â¦r ecu rÂ¦ Â¦forÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦twoÂ¦ Â¦mon thsÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦l istÂ¦ Â¦withÂ¦ Â¦ex a mp lesÂ¦ Â¦inclu desÂ¦ Â¦diseasesÂ¦ Â¦forÂ¦ Â¦whichÂ¦ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦inclu dedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦nationalÂ¦ Â¦immun is ationÂ¦ Â¦pr ogra mm esÂ¦ ,â– Â¦andÂ¦ / Â¦orÂ¦ Â¦areÂ¦ Â¦giv enÂ¦ Â¦toÂ¦ Â¦pers onsÂ¦ Â¦consid eredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦atÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦gettingÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦vaccinesÂ¦ Â¦protectÂ¦ Â¦peopleÂ¦ Â¦duringÂ¦ Â¦differentÂ¦ Â¦sta gesÂ¦ Â¦ofÂ¦ Â¦l ifeÂ¦ .
ğ‹‡ Â¦nationalÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ Â¦inÂ¦  /  Â¦countriesÂ¦ Â¦recomm endÂ¦ Â¦vaccinesÂ¦ Â¦atÂ¦ Â¦specificÂ¦ Â¦a gesÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦specificÂ¦ Â¦p op ul ationsÂ¦ .
ğ‹‡ Â¦healthcareÂ¦ Â¦pro f es si on alsÂ¦
ğ‹‡Â¦someÂ¦ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦notÂ¦ Â¦par tÂ¦ Â¦ofÂ¦ Â¦ro ut ineÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ Â¦butÂ¦ Â¦areÂ¦ Â¦t ar ge tedÂ¦ Â¦atÂ¦ Â¦specificÂ¦ Â¦grou psÂ¦ .
ğ‹‡ Â¦eachÂ¦  /  Â¦countryÂ¦ Â¦isÂ¦ Â¦resp on si bleÂ¦ Â¦forÂ¦ Â¦itsÂ¦ Â¦ ownÂ¦ Â¦nationalÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦pol ic yÂ¦ ,â– Â¦includingÂ¦ Â¦itsÂ¦ Â¦nationalÂ¦ Â¦immun is ationÂ¦ Â¦pr ogra m meÂ¦ Â¦andÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u leÂ¦ .â– ğ‹‡ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦nationalÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ Â¦inÂ¦  /  Â¦countriesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦  ğ‹‡ Â¦vaccineÂ¦ ğ‹‡Â¦s ch ed ul erÂ¦
ğ‹‡Â¦thereÂ¦ Â¦areÂ¦ Â¦someÂ¦ Â¦di ff er en cesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦wayÂ¦ Â¦countriesÂ¦ Â¦or g an iseÂ¦ Â¦theirÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦similarÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦ident icalÂ¦ Â¦inÂ¦ Â¦differentÂ¦  /  Â¦countriesÂ¦ .
ğ‹‡ Â¦fa ctorsÂ¦ Â¦d ri vingÂ¦ Â¦suchÂ¦ Â¦di ff er en cesÂ¦ Â¦mayÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ' Â¦sÂ¦ Â¦b ur d enÂ¦ ,â– Â¦prev al enceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦tr endsÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦countriesÂ¦ ,â– Â¦theÂ¦ Â¦res o ur cesÂ¦ Â¦andÂ¦ Â¦st ru ct uresÂ¦ Â¦ofÂ¦ Â¦healthcareÂ¦ Â¦sys temsÂ¦ ,â– Â¦pol it icalÂ¦ Â¦andÂ¦ Â¦c ult uralÂ¦ Â¦fa ctorsÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦re si li enceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vacc inationÂ¦ Â¦pr ogra m meÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦di ff er en cesÂ¦ Â¦betweenÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦me anÂ¦ Â¦thatÂ¦ Â¦someÂ¦ Â¦areÂ¦ Â¦bet terÂ¦ Â¦thanÂ¦ Â¦othersÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ch ild h oodÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ Â¦inÂ¦ Â¦allÂ¦  /  Â¦countriesÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦vacc inationÂ¦ Â¦againstÂ¦ :
Â¦me as lesÂ¦
Â¦m um psÂ¦
Â¦r ub e ll aÂ¦
Â¦di ph ther iaÂ¦
Â¦t et an usÂ¦
Â¦per t us sisÂ¦ â–( Â¦w ho op ingÂ¦ Â¦coughÂ¦ )
Â¦po li om y el itisÂ¦
ğ‹‡ Â¦ha e mo ph il usÂ¦ Â¦influ en z a eÂ¦ Â¦typ eÂ¦ ğ‹‡Â¦b Â¦
Â¦humanÂ¦ Â¦p ap il lo ma vir usÂ¦ â–( Â¦ad ol esc entÂ¦ / Â¦pr eÂ¦ - Â¦ad ol esc entÂ¦ Â¦g ir l sÂ¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦worldÂ¦ ğ‹‡ Â¦healthÂ¦ ğ‹‡ Â¦organiz ationÂ¦ â–(  )â– Â¦recomm endsÂ¦ Â¦vacc inationÂ¦ Â¦againstÂ¦ Â¦he p at itisÂ¦ ğ‹‡Â¦b Â¦ Â¦asÂ¦ Â¦par tÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦univers alÂ¦ Â¦ch ild h oodÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u leÂ¦ ,â– Â¦butÂ¦ Â¦someÂ¦  /  Â¦countriesÂ¦ Â¦onlyÂ¦ Â¦vacc in ateÂ¦ Â¦childrenÂ¦ Â¦atÂ¦ Â¦highÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ Â¦andÂ¦ Â¦ad ul tsÂ¦ Â¦inÂ¦ Â¦k e yÂ¦ Â¦riskÂ¦ Â¦grou psÂ¦ .
ğ‹‡ Â¦childrenÂ¦ Â¦inÂ¦ Â¦someÂ¦  /  Â¦countriesÂ¦ Â¦areÂ¦ Â¦off eredÂ¦ Â¦prote ctionÂ¦ Â¦throughÂ¦ Â¦vacc inationÂ¦ Â¦againstÂ¦ :
Â¦he p at itisÂ¦ ğ‹‡Â¦aÂ¦
Â¦influenzaÂ¦
Â¦inv as iveÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦ne i ss er iaÂ¦ Â¦m en i ng i ti di sÂ¦
Â¦inv as iveÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğ‹‡ Â¦st re pt oc oc c usÂ¦ Â¦p ne um on ia eÂ¦
Â¦ro ta vir usÂ¦
Â¦t ub erc u lo sisÂ¦
Â¦vari ce ll aÂ¦
ğ‹‡Â¦inÂ¦ Â¦add itionÂ¦ ,â– Â¦allÂ¦  /  Â¦countriesÂ¦ Â¦haveÂ¦ Â¦recomm end ationsÂ¦ Â¦forÂ¦ Â¦se as on alÂ¦ Â¦influenzaÂ¦ â–( Â¦fluÂ¦ )â– Â¦forÂ¦ Â¦ ol derÂ¦ Â¦peopleÂ¦ Â¦andÂ¦ Â¦k e yÂ¦ Â¦riskÂ¦ Â¦grou psÂ¦ .
ğ‹‡Â¦theÂ¦  Â¦isÂ¦ Â¦ex pl or ingÂ¦ Â¦furtherÂ¦ Â¦h arm on is ationÂ¦ Â¦ofÂ¦ Â¦nationalÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ .â– ğ‹‡Â¦theÂ¦  ğ‹‡ Â¦cou nc ilÂ¦ Â¦issuedÂ¦ ğ‹‡ Â¦recomm end ationsÂ¦ Â¦onÂ¦ Â¦7Â¦ ğ‹‡ Â¦decemberÂ¦ Â¦20 1 8Â¦
Â¦onÂ¦ Â¦st re ng t he nedÂ¦ Â¦co op er ationÂ¦ Â¦againstÂ¦ Â¦vaccineÂ¦ - Â¦pre vent ableÂ¦ Â¦diseasesÂ¦ ,â– Â¦whichÂ¦ Â¦includeÂ¦ Â¦ex a mi ningÂ¦ Â¦theÂ¦ Â¦f ea si bilityÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦c oreÂ¦  Â¦vacc inationÂ¦ Â¦s ch ed u leÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ ai mÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦toÂ¦ Â¦imp ro veÂ¦ Â¦theÂ¦ Â¦comp a ti bilityÂ¦ Â¦ofÂ¦ Â¦nationalÂ¦ Â¦vacc inationÂ¦ Â¦s ch ed u lesÂ¦ Â¦andÂ¦ Â¦pr om ot eÂ¦ Â¦e q ualÂ¦ Â¦acc essÂ¦ Â¦toÂ¦ Â¦vacc in ationsÂ¦ Â¦acrossÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦eachÂ¦  /  Â¦countryÂ¦ Â¦imp le mentsÂ¦ Â¦itsÂ¦ Â¦ ownÂ¦ Â¦immun is ationÂ¦ Â¦pr ogra m meÂ¦ .
 /  Â¦countriesÂ¦ Â¦haveÂ¦ Â¦a ch ie v edÂ¦ Â¦highÂ¦ Â¦vacc inationÂ¦ Â¦co ver ageÂ¦ Â¦r atesÂ¦ Â¦throughÂ¦ Â¦mand atoryÂ¦ Â¦andÂ¦ Â¦nonÂ¦ - Â¦mand atoryÂ¦ Â¦vacc inationÂ¦ .
ğ‹‡ Â¦eachÂ¦  /  Â¦countryÂ¦ Â¦dec i desÂ¦ Â¦ifÂ¦ Â¦vacc inationÂ¦ Â¦isÂ¦ Â¦mand atoryÂ¦ Â¦orÂ¦ Â¦v o lu nt aryÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦ter r it oryÂ¦ .
ğ‹‡ Â¦informationÂ¦ Â¦onÂ¦ Â¦whichÂ¦ Â¦countriesÂ¦ Â¦haveÂ¦ Â¦mand atoryÂ¦ Â¦vacc inationÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦vaccineÂ¦ ğ‹‡Â¦s ch ed ul erÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦peopleÂ¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦m is sedÂ¦ Â¦aÂ¦ Â¦vacc inationÂ¦ Â¦orÂ¦ Â¦d idÂ¦ Â¦notÂ¦ Â¦getÂ¦ Â¦theÂ¦ Â¦recommendedÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦dosesÂ¦ .
ğ‹‡Â¦e veryoneÂ¦ Â¦shouldÂ¦ Â¦ch eckÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦theÂ¦ Â¦na tion allyÂ¦ Â¦recommendedÂ¦ Â¦vacc in ationsÂ¦ ,â– Â¦andÂ¦ Â¦cons ul tÂ¦ Â¦aÂ¦ Â¦medicalÂ¦ Â¦pro f es si on alÂ¦ Â¦inÂ¦ Â¦caseÂ¦ Â¦anyÂ¦ Â¦c at chÂ¦ - Â¦u psÂ¦ Â¦areÂ¦ Â¦nee dedÂ¦ .
ğ‹‡Â¦ifÂ¦ Â¦aÂ¦ Â¦personÂ¦ Â¦doesÂ¦ Â¦notÂ¦ Â¦knowÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦vaccinatedÂ¦ Â¦againstÂ¦ Â¦aÂ¦ Â¦c er tainÂ¦ Â¦diseaseÂ¦ Â¦theyÂ¦ Â¦canÂ¦ Â¦us uallyÂ¦ Â¦getÂ¦ Â¦anÂ¦ Â¦ext r aÂ¦ Â¦d oseÂ¦ Â¦withoutÂ¦ Â¦incre as ingÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦ser iousÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ â–( Â¦1Â¦ ).
Â¦me as lesÂ¦ Â¦vaccineÂ¦
 Â¦i ğ‹‡ st oc kÂ¦
ğ‹‡Â¦c at chÂ¦ - Â¦upÂ¦ Â¦vacc inationÂ¦ Â¦pr ogra mm esÂ¦ Â¦forÂ¦ Â¦specificÂ¦ Â¦diseasesÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦or g an i sedÂ¦ .
ğ‹‡ Â¦mostÂ¦ Â¦vaccinesÂ¦ Â¦provideÂ¦ Â¦l if e lo ngÂ¦ Â¦immun ityÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦someÂ¦ Â¦vaccinesÂ¦ Â¦provideÂ¦ Â¦immun ityÂ¦ Â¦thatÂ¦ Â¦dec rea sesÂ¦ Â¦overÂ¦ Â¦timeÂ¦ ,â– Â¦knownÂ¦ Â¦asÂ¦ â– â€˜ Â¦w a ningÂ¦ Â¦immun ityÂ¦ â€™ .â– ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦recomm endÂ¦ Â¦ bo os terÂ¦ Â¦dosesÂ¦ Â¦atÂ¦ Â¦reg ularÂ¦ Â¦int erv alsÂ¦ Â¦duringÂ¦ Â¦ad ol esc enceÂ¦ Â¦andÂ¦ Â¦ad ul th oodÂ¦ ,â– Â¦inÂ¦ Â¦orderÂ¦ Â¦toÂ¦ Â¦main tainÂ¦ Â¦immun ityÂ¦ Â¦overÂ¦ Â¦aÂ¦ Â¦lo ngerÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ Â¦timeÂ¦ ,â– Â¦againstÂ¦ Â¦forÂ¦ Â¦exampleÂ¦ :
Â¦di ph ther iaÂ¦
Â¦t et an usÂ¦
Â¦per t us sisÂ¦ â–( Â¦w ho op ingÂ¦ Â¦coughÂ¦ )
ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦recomm endÂ¦ Â¦b oo st ersÂ¦ Â¦spec if icallyÂ¦ Â¦forÂ¦ Â¦individualsÂ¦ Â¦tra ve llingÂ¦ Â¦orÂ¦ Â¦atÂ¦ Â¦increasedÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦beingÂ¦ Â¦exp osedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .â–
ğ‹‡ Â¦healthcareÂ¦ Â¦provid ersÂ¦ Â¦canÂ¦ Â¦provideÂ¦ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ bo os terÂ¦ Â¦dosesÂ¦ Â¦nee dedÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦vaccineÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦contr ai nd ic atedÂ¦ Â¦forÂ¦ Â¦c er tainÂ¦ Â¦peopleÂ¦ ,â– Â¦m ea ningÂ¦ Â¦theyÂ¦ Â¦shouldÂ¦ Â¦notÂ¦ Â¦receiveÂ¦ Â¦itÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦contr ai nd ic atedÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦all er g icÂ¦ Â¦toÂ¦ Â¦anyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦ac tiveÂ¦ Â¦sub st an cesÂ¦ Â¦orÂ¦ Â¦i ng re di entsÂ¦ Â¦asÂ¦ Â¦l is tedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦produc tÂ¦ Â¦informationÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦h ist oryÂ¦ Â¦ofÂ¦ â–' Â¦a na ph y la ct icÂ¦ ' â– Â¦orÂ¦ Â¦otherÂ¦ Â¦ser iousÂ¦ Â¦all er g icÂ¦ Â¦rea ctionÂ¦ Â¦afterÂ¦ Â¦rece i vingÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦contr ai nd ic ationÂ¦ Â¦toÂ¦ Â¦furtherÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦thatÂ¦ Â¦vaccineÂ¦ .
ğ‹‡Â¦c er tainÂ¦ Â¦immuneÂ¦ Â¦systemÂ¦ Â¦dis or d ersÂ¦ â–( Â¦ eÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦someÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦co mpl et ionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦immun is ationsÂ¦ Â¦nee dedÂ¦ Â¦isÂ¦ Â¦recommendedÂ¦ Â¦pri orÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦star tÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦treatmentÂ¦ ,â– Â¦asÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦theÂ¦ Â¦pa ti entÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦atÂ¦ Â¦higherÂ¦ Â¦r is ksÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦contr ai nd ic atedÂ¦ Â¦duringÂ¦ Â¦pregn a ncyÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦me as lesÂ¦ ,â– Â¦m um psÂ¦ Â¦andÂ¦ Â¦r ub e ll aÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦otherÂ¦ Â¦contr ai nd icationsÂ¦ Â¦forÂ¦ Â¦specificÂ¦ Â¦vaccinesÂ¦ ,â– Â¦whichÂ¦ Â¦needÂ¦ Â¦disc u ss ingÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦healthcareÂ¦ Â¦provid erÂ¦ .
ğ‹‡ Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦usedÂ¦ Â¦worldwideÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦high lyÂ¦ Â¦effectiveÂ¦ Â¦wayÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦contr ac tingÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦vaccineÂ¦ Â¦wasÂ¦ Â¦developedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦1 8 thÂ¦ Â¦ce nt u ryÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ .
ğ‹‡Â¦n ow a d aysÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦vaccinesÂ¦ Â¦forÂ¦ Â¦manyÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦v ide oÂ¦ Â¦isÂ¦ Â¦availableÂ¦ Â¦inÂ¦ Â¦24Â¦  Â¦la ng u a gesÂ¦ .
ğ‹‡ Â¦safetyÂ¦ ,â– Â¦qu alityÂ¦ Â¦andÂ¦ Â¦sta nd ardsÂ¦
ğ‹‡ Â¦beforeÂ¦ Â¦anyÂ¦ Â¦newÂ¦ Â¦vaccineÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦toÂ¦ Â¦under g oÂ¦ Â¦r ig o ro usÂ¦ Â¦testingÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦ev a lu ationÂ¦ Â¦needsÂ¦ Â¦toÂ¦ Â¦sh owÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦be ne f i tsÂ¦ Â¦inÂ¦ Â¦prot ectingÂ¦ Â¦peopleÂ¦ Â¦againstÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦fa rÂ¦ Â¦g rea terÂ¦ Â¦thanÂ¦ Â¦anyÂ¦ Â¦pote ntialÂ¦ Â¦riskÂ¦ .
ğ‹‡ Â¦onlyÂ¦ Â¦thenÂ¦ ,â– Â¦afterÂ¦ Â¦appr ov alÂ¦ ,â– Â¦canÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦beÂ¦ Â¦m an u fa ct ur edÂ¦ ,â– Â¦mark e tedÂ¦ Â¦andÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦protectÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦medic ineÂ¦ ,â– Â¦someÂ¦ Â¦peopleÂ¦ Â¦mayÂ¦ Â¦exp eri enceÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ ,â– Â¦butÂ¦ Â¦theseÂ¦ Â¦areÂ¦ Â¦us uallyÂ¦ Â¦mildÂ¦ Â¦andÂ¦ Â¦sh ortÂ¦ - Â¦l iv edÂ¦ .
ğ‹‡ Â¦be ne f i tsÂ¦ Â¦ofÂ¦ Â¦vacc in atingÂ¦
ğ‹‡ Â¦vaccinesÂ¦ Â¦preventÂ¦ Â¦diseasesÂ¦ Â¦thatÂ¦ Â¦couldÂ¦ Â¦o ther w iseÂ¦ Â¦causeÂ¦ Â¦ser iousÂ¦ Â¦healthÂ¦ Â¦prob le msÂ¦ ,â– Â¦p erm an entÂ¦ Â¦dis a bilityÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦deathÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– Â¦duringÂ¦ Â¦20 1 8Â¦ Â¦aboutÂ¦ Â¦8 6Â¦ %â– Â¦ofÂ¦ Â¦in fa ntsÂ¦ Â¦worldwideÂ¦ Â¦receivedÂ¦ Â¦threeÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦thatÂ¦ Â¦prot ectsÂ¦ Â¦themÂ¦ Â¦againstÂ¦ Â¦di ph ther iaÂ¦ ,â– Â¦t et an usÂ¦ Â¦andÂ¦ Â¦per t us sisÂ¦ â–(  ),â– Â¦andÂ¦ Â¦8 5Â¦ %â– Â¦ofÂ¦ Â¦in fa ntsÂ¦ Â¦aroundÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦receivedÂ¦ Â¦threeÂ¦ Â¦dosesÂ¦ Â¦ofÂ¦ Â¦po li oÂ¦ Â¦vaccineÂ¦ â–( Â¦1Â¦ ).
ğ‹‡ Â¦un li keÂ¦ Â¦aÂ¦ Â¦treatmentÂ¦ Â¦giv enÂ¦ Â¦toÂ¦ Â¦c ureÂ¦ Â¦anÂ¦ Â¦illnessÂ¦ ,â– Â¦vaccinesÂ¦ Â¦areÂ¦ Â¦us uallyÂ¦ Â¦giv enÂ¦ Â¦toÂ¦ Â¦healthyÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦themÂ¦ Â¦fromÂ¦ Â¦gettingÂ¦ Â¦ illÂ¦ .
ğ‹‡ Â¦manyÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦veryÂ¦ Â¦r areÂ¦ Â¦to dayÂ¦ Â¦th an ksÂ¦ Â¦toÂ¦ Â¦vacc inationÂ¦ ,â– Â¦soÂ¦ Â¦theÂ¦ Â¦negativeÂ¦ Â¦con se qu en cesÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦s om et im esÂ¦ Â¦for g ot t enÂ¦ .
ğ‹‡ Â¦exampleÂ¦ :â– Â¦me as lesÂ¦
ğ‹‡ Â¦me as lesÂ¦ Â¦hadÂ¦ Â¦al m ostÂ¦ Â¦beenÂ¦ Â¦e li min atedÂ¦ Â¦inÂ¦ Â¦manyÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦sinceÂ¦ ğ‹‡ Â¦o ct ob erÂ¦ Â¦20 1 6Â¦ Â¦aÂ¦ Â¦res ur g enceÂ¦ Â¦ofÂ¦ Â¦me as lesÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦ob s erv edÂ¦ Â¦inÂ¦ Â¦theÂ¦  /  ,â– Â¦withÂ¦ Â¦out b rea ksÂ¦ Â¦inÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ â–( Â¦2Â¦ ),â– Â¦dueÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦dec lineÂ¦ Â¦inÂ¦ Â¦vacc inationÂ¦ Â¦r atesÂ¦ .
ğ‹‡ Â¦me as lesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦ser iousÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦l ifeÂ¦ - Â¦th re at eningÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦onlyÂ¦ Â¦prote ctionÂ¦ Â¦againstÂ¦ Â¦me as lesÂ¦ Â¦isÂ¦ Â¦vacc inationÂ¦ .
ğ‹‡ Â¦exampleÂ¦ :â– Â¦per t us sisÂ¦
ğ‹‡Â¦p e rt us sisÂ¦ â–( Â¦w ho op ingÂ¦ Â¦coughÂ¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ Â¦aff ectingÂ¦ Â¦theÂ¦ Â¦air w aysÂ¦ .
ğ‹‡ Â¦co mpl icationsÂ¦ Â¦canÂ¦ Â¦includeÂ¦ Â¦pneumoniaÂ¦ ,â– Â¦en ce ph a lo pa th yÂ¦ â–( Â¦aÂ¦ Â¦diseaseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦b ra inÂ¦ ),â– Â¦se iz uresÂ¦ Â¦andÂ¦ Â¦evenÂ¦ Â¦deathÂ¦ .
ğ‹‡ Â¦vacc inationÂ¦ Â¦againstÂ¦ Â¦per t us sisÂ¦ Â¦isÂ¦ Â¦par tÂ¦ Â¦ofÂ¦ Â¦nationalÂ¦ Â¦immun is ationÂ¦ Â¦pr ogra mm esÂ¦ Â¦inÂ¦ Â¦theÂ¦  .
ğ‹‡ Â¦appr ov alÂ¦ Â¦ofÂ¦ Â¦vaccinesÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦un ionÂ¦
ğ‹‡ Â¦beforeÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦appr ovedÂ¦ Â¦inÂ¦ Â¦theÂ¦  ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦toÂ¦ Â¦under g oÂ¦ Â¦r ig o ro usÂ¦ Â¦testingÂ¦ Â¦byÂ¦ Â¦itsÂ¦ Â¦develop erÂ¦ Â¦andÂ¦ Â¦thenÂ¦ Â¦sc ie nt if icÂ¦ Â¦ev a lu ationÂ¦ Â¦byÂ¦ Â¦regul atoryÂ¦ Â¦author itiesÂ¦ .
ğ‹‡ Â¦testingÂ¦ Â¦inclu desÂ¦ Â¦chec kingÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦qu alityÂ¦ :
Â¦itsÂ¦ Â¦p ur ityÂ¦ ;
Â¦itsÂ¦ Â¦i ng re di entsÂ¦ ,â– Â¦includingÂ¦ Â¦itsÂ¦ Â¦in ac tiveÂ¦ Â¦i ng re di entsÂ¦ Â¦orÂ¦ â– â€˜ Â¦ex c ip i entsÂ¦ â€™ ;
Â¦howÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦m an u fa ct ur edÂ¦ .
ğ‹‡ Â¦thenÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦develop erÂ¦ Â¦testsÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦eff ectsÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦fo ll owedÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦clinicalÂ¦ Â¦testingÂ¦ Â¦pr ogra m meÂ¦ Â¦inÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦canÂ¦ Â¦takeÂ¦ Â¦aroundÂ¦ Â¦t enÂ¦ Â¦yearsÂ¦ Â¦fromÂ¦ Â¦in it ialÂ¦ Â¦con cep tÂ¦ Â¦toÂ¦ Â¦author is ationÂ¦ .
Â¦20Â¦ â–-â– Â¦100Â¦ Â¦healthyÂ¦ Â¦v ol un te ersÂ¦
ğ‹‡ Â¦whatÂ¦ Â¦isÂ¦ Â¦chec kedÂ¦ :â–
ğ‹‡ Â¦doesÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦s ee mÂ¦ Â¦toÂ¦ Â¦workÂ¦ ?
ğ‹‡ Â¦areÂ¦ Â¦thereÂ¦ Â¦ser iousÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ ?
ğ‹‡ Â¦isÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦safeÂ¦ ?
ğ‹‡ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦testingÂ¦ Â¦pr ogra m meÂ¦ ,â– Â¦theÂ¦ Â¦vaccineÂ¦ Â¦develop erÂ¦ Â¦sub mi tsÂ¦ Â¦theÂ¦ Â¦resultsÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦medic inesÂ¦ Â¦regul atoryÂ¦ Â¦author itiesÂ¦ Â¦inÂ¦ ğ‹‡Â¦e ur opeÂ¦ Â¦asÂ¦ Â¦par tÂ¦ Â¦ofÂ¦ Â¦aÂ¦ â– â€˜ Â¦mark e tingÂ¦ Â¦author is ationÂ¦ â€™ â– Â¦app l ic ationÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦regul at orsÂ¦ Â¦canÂ¦ Â¦onlyÂ¦ Â¦appro veÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦ifÂ¦ Â¦itsÂ¦ Â¦sc ie nt if icÂ¦ Â¦ev a lu ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦testsÂ¦ Â¦resultsÂ¦ Â¦sh owÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ â€™ Â¦sÂ¦ Â¦be ne f i tsÂ¦ Â¦areÂ¦ Â¦g rea terÂ¦ Â¦thanÂ¦ Â¦itsÂ¦ Â¦r is ksÂ¦ .
ğ‹‡ Â¦medic inesÂ¦ Â¦regul atoryÂ¦ Â¦author itiesÂ¦ Â¦canÂ¦ Â¦car ryÂ¦ Â¦outÂ¦ Â¦i ns p ec tionsÂ¦ Â¦toÂ¦ Â¦makeÂ¦ Â¦sureÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦informationÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦develop erÂ¦ Â¦provid esÂ¦ Â¦isÂ¦ Â¦t ru st w or th yÂ¦ .
ğ‹‡ Â¦monit or ingÂ¦ Â¦vaccineÂ¦ Â¦safetyÂ¦ Â¦andÂ¦ Â¦rep ortingÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦
ğ‹‡ Â¦o nceÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦appr ovedÂ¦ Â¦forÂ¦ Â¦useÂ¦ ,â–  /  Â¦nationalÂ¦ Â¦author itiesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ ğ‹‡ Â¦medic inesÂ¦ ğ‹‡ Â¦a ge ncyÂ¦
(  ),â– Â¦contin uallyÂ¦ Â¦monit orÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ Â¦inÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦receivedÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦e ns uresÂ¦ Â¦thatÂ¦ Â¦anyÂ¦ Â¦possibleÂ¦ Â¦r is ksÂ¦ Â¦areÂ¦ Â¦detectedÂ¦ Â¦andÂ¦ Â¦mana gedÂ¦ Â¦asÂ¦ Â¦so onÂ¦ Â¦asÂ¦ Â¦possibleÂ¦ .
 Â¦chec ksÂ¦ Â¦newÂ¦ Â¦informationÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦safetyÂ¦ Â¦ofÂ¦ Â¦allÂ¦ Â¦vaccinesÂ¦ Â¦availableÂ¦ Â¦inÂ¦ ğ‹‡Â¦e ur opeÂ¦ .â– ğ‹‡Â¦itÂ¦ Â¦anal y sesÂ¦ Â¦manyÂ¦ Â¦sour cesÂ¦ Â¦ofÂ¦ Â¦dataÂ¦ ,â– Â¦includingÂ¦ :
Â¦rep ortsÂ¦ Â¦fromÂ¦ Â¦patientsÂ¦ ,â– Â¦par entsÂ¦ Â¦andÂ¦ Â¦healthcareÂ¦ Â¦pro f es si on alsÂ¦ ;
Â¦clinicalÂ¦ Â¦st u diesÂ¦ ;
Â¦theÂ¦ Â¦medicalÂ¦ Â¦l it erat ureÂ¦ ;
Â¦informationÂ¦ Â¦sh aredÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦regul at orsÂ¦ .
 Â¦ca re f ul lyÂ¦ Â¦ass es sesÂ¦ Â¦suspectedÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ Â¦toÂ¦ Â¦det erm ineÂ¦ Â¦ifÂ¦ Â¦thereÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦ca us alÂ¦ Â¦l inkÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦vaccineÂ¦ Â¦orÂ¦ Â¦notÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦v ide oÂ¦ Â¦isÂ¦ Â¦availableÂ¦ Â¦inÂ¦ Â¦24Â¦  Â¦la ng u a gesÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦nee dedÂ¦ ,â–  Â¦andÂ¦ Â¦theÂ¦ Â¦otherÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦regul at orsÂ¦ Â¦takeÂ¦ Â¦a ctionÂ¦ .
ğ‹‡ Â¦patientsÂ¦ ,â– Â¦healthcareÂ¦ Â¦pro f es si on alsÂ¦ Â¦andÂ¦ Â¦ph ar ma ce ut icalÂ¦ Â¦comp an iesÂ¦ Â¦shouldÂ¦ Â¦reportÂ¦ Â¦allÂ¦ Â¦suspectedÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦nationalÂ¦ Â¦medic inesÂ¦ Â¦regul atoryÂ¦ Â¦author ityÂ¦ .
ğ‹‡ Â¦informationÂ¦ Â¦onÂ¦ Â¦theseÂ¦ Â¦reportedÂ¦ Â¦suspectedÂ¦ Â¦ sideÂ¦ Â¦eff ectsÂ¦ Â¦isÂ¦ Â¦publ ic lyÂ¦ Â¦availableÂ¦ Â¦onÂ¦ Â¦theÂ¦ ğ‹‡ Â¦europeanÂ¦ Â¦d at ab aseÂ¦ Â¦ofÂ¦ Â¦suspectedÂ¦ Â¦ad ver seÂ¦ Â¦drugÂ¦ Â¦rea ctionÂ¦ Â¦rep ortsÂ¦ .â–
ğ‹‡Â¦theÂ¦ Â¦proc essÂ¦ Â¦ofÂ¦ Â¦monit or ingÂ¦ Â¦theÂ¦ Â¦safetyÂ¦ Â¦andÂ¦ Â¦mana gingÂ¦ Â¦theÂ¦ Â¦r is ksÂ¦ Â¦ofÂ¦ Â¦medic inesÂ¦ Â¦isÂ¦ Â¦calledÂ¦ â– â€˜ Â¦ph ar ma cov ig il anceÂ¦ â€™ .
ğ‹‡ Â¦vaccineÂ¦ Â¦eff ec ti ve nessÂ¦
ğ‹‡Â¦aÂ¦ Â¦vaccineÂ¦ ' Â¦sÂ¦ Â¦a bilityÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦aÂ¦ Â¦specificÂ¦ Â¦diseaseÂ¦ Â¦det erm inesÂ¦ Â¦itsÂ¦ Â¦eff ec ti ve nessÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦medic ineÂ¦ ,â– Â¦noÂ¦ Â¦vaccineÂ¦ Â¦isÂ¦ Â¦100Â¦ %â– Â¦effectiveÂ¦ Â¦inÂ¦ Â¦everyÂ¦ Â¦personÂ¦ Â¦vaccinatedÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦includeÂ¦ :
